Document:

Exhibit 10.11 

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (“Agreement”)
is made as of the 22nd of January, 2021 between Gemini Therapeutics, Inc., a Delaware corporation (the “Company”),
and Dr. Scott Lauder (the “Executive”).

 

WHEREAS, the Company desires to continue
to employ the Executive and the Executive desires to continue to be employed by the Company on the terms and conditions contained
herein commencing on February 5, 2021, unless another date is agreed to by the parties. The Executive’s first day of employment
under this Agreement shall be the “Effective Date” of this Agreement; and

 

WHEREAS, the Company provided the Executive
with this Agreement, which is its formal offer of employment to the Executive, at least ten (10) business days before the Effective
Date. The Executive has the right to consult with counsel prior to signing this Agreement.

 

NOW, THEREFORE, in consideration of the
mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the parties agree as follows:

 

1.
Employment.

 

(a)
Term. The Company shall employ the Executive and the Executive shall be employed by the Company pursuant to this
Agreement commencing as of the Effective Date and continuing until such employment is terminated in accordance with the provisions
hereof (the “Term”). The Executive’s employment with the Company shall be “at will,” meaning that
the Executive’s employment may be terminated by the Company or the Executive at any time and for any reason subject to the
terms of this Agreement.

 

(b)
Position and Duties. During the Term, the Executive shall serve as the Chief Technology Officer for the Company and
shall have such powers and duties as may from time to time be prescribed by the Chief Executive Officer of the Company (the “CEO”).
The Executive shall devote his full working time and efforts to the business and affairs of the Company. Notwithstanding the foregoing,
the Executive may serve on other boards of directors, with the approval of the Board of Directors of the Company (the “Board”)
or a committee of the Board, or engage in religious, charitable or other community activities as long as such services and activities
are disclosed to the Board and do not interfere with the Executive’s performance of his duties to the Company.

 

2.
Compensation and Related Matters.

 

(a)
Base Salary. During the Term, the Executive’s initial annual base salary shall be paid at the rate of $411,650
per year. The Executive’s base salary shall be reviewed annually by the Board or the Compensation Committee of the Board
(the “Compensation Committee”). The base salary in effect at any given time is referred to herein as “Base Salary.”
The Base Salary shall be payable in a manner that is consistent with the Company’s usual payroll practices for senior executives.

 

    

     

    

 

(b)
Incentive Compensation. During the Term, the Executive shall be eligible to receive cash incentive compensation as
determined by the Board or the Compensation Committee from time to time. The Executive’s target annual incentive compensation
shall be 40% of the Base Salary (the “Target Bonus”). Except as otherwise provided herein, to earn incentive compensation,
the Executive must be employed by the Company on the day such incentive compensation is paid.

 

(c)
Expenses. The Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by
them during the Term in performing services hereunder, in accordance with the policies and procedures then in effect and established
by the Company for its senior executives.

 

(d)
Other Benefits. During the Term, the Executive shall be eligible to participate in or receive benefits under the
Company’s policies and employee benefit plans in effect from time to time, subject to the terms of such policies and plans
and to the Company’s ability to amend, modify, replace or terminate such policies and plans, including with respect to paid
time off.

 

(e)
Intentionally Omitted.

 

(f)
Withholding; Tax Effect. All payments made by the Company to the Executive under this Agreement shall be net of any
tax or other amounts required to be withheld by the Company under applicable law. Nothing in this Agreement shall be construed
to require the Company to make any payments to compensate the Executive for any adverse tax effect associated with any payments
or benefits or for any deduction or withholding from any payment or benefit.

 

3.
Termination. During the Term, the Executive’s employment hereunder may be terminated without any breach of
this Agreement under the following circumstances:

 

(a)
Death. The Executive’s employment hereunder shall terminate upon his death.

 

(b)
Disability. The Company may terminate the Executive’s employment if they are disabled and unable to perform
the essential functions of the Executive’s then existing position or positions under this Agreement with or without reasonable
accommodation for a period of 180 days (which need not be consecutive) in any 12-month period. If any question shall arise as to
whether during any period the Executive is disabled so as to be unable to perform the essential functions of the Executive’s
then existing position or positions with or without reasonable accommodation, the Executive may, and at the request of the Company
shall, submit to the Company a certification in reasonable detail by a physician selected by the Company to whom the Executive
or the Executive’s guardian has no reasonable objection as to whether the Executive is so disabled or how long such disability
is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. The Executive
shall cooperate with any reasonable request of the physician in connection with such certification. If such question shall arise
and the Executive shall fail to submit such certification, the Company’s determination of such issue shall be binding on
the Executive. Nothing in this Section 3(b) shall be construed to waive the Executive’s rights, if any, under existing law
including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the Americans
with Disabilities Act, 42 U.S.C. §12101 et seq.

 

    2

     

    

 

(c)
Termination by Company for Cause. The Company may terminate the Executive’s employment hereunder for Cause.
For purposes of this Agreement, “Cause” shall mean: (i) conduct by the Executive constituting a material act of misconduct
in connection with the performance of his duties, including, without limitation, misappropriation of funds or property of the Company
or any of its subsidiaries or affiliates other than the occasional, customary and de minimis use of Company property for personal
purposes; (ii) the commission by the Executive of any felony or a misdemeanor involving moral turpitude, deceit, dishonesty or
fraud, or any conduct by the Executive that would reasonably be expected to result in material injury or reputational harm to the
Company or any of its subsidiaries and affiliates if they were retained in his position; (iii) unsatisfactory performance by the
Executive of a material responsibility (other than by reason of the Executive’s physical or mental illness, incapacity or
disability) as reasonably determined by the CEO, which has continued for not less than 30 days following written notice from the
CEO that identifies the unsatisfactory performance; (iv) a breach by the Executive of any of the provisions contained in Section
8 of this Agreement; (v) a material violation by the Executive of the Company’s written employment policies; or (vi) failure
to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being
instructed by the Company to cooperate, or the willful destruction or failure to preserve documents or other materials known to
be relevant to such investigation or the inducement of others to fail to cooperate or to produce documents or other materials in
connection with such investigation.

 

(d)
Termination without Cause. The Company may terminate the Executive’s employment hereunder at any time without
Cause. Any termination by the Company of the Executive’s employment under this Agreement which does not constitute a termination
for Cause under Section 3(c) and does not result from the death or disability of the Executive under Section 3(a) or (b) shall
be deemed a termination without Cause.

 

(e)
Termination by the Executive. The Executive may terminate his employment hereunder at any time for any reason, including
for Good Reason. For purposes of this offer letter, “Good Reason” shall mean that the Executive has complied with the
“Good Reason Process” (hereinafter defined) following the occurrence of any of the following events: (i) reduction
of the Executive’s Base Salary without the Executive’s prior consent (other than in connection with, and substantially
proportionate to, reductions by the Company of the compensation of the Company’s management employees); (ii) material diminution
in the Executive’s responsibilities, authority, or duties, without the Executive’s prior consent; (iii) unless
the Executive and the Company mutually agree the remote work location for the Executive, relocation of the Company’s offices
more than 100 miles away from the current location without the Executive’s prior consent; or (iv) any material breach by
the Company or any successor thereto of this Agreement. “Good Reason Process” shall mean that (i) the Executive has
reasonably determined in good faith that a “Good Reason” condition has occurred; (ii) the Executive has notified the
Company in writing of the first occurrence of the Good Reason condition within 90 days of the first occurrence of such condition;
(iii) the Executive has cooperated in good faith with the Company’s efforts, for a period not less than 30 days following
such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition
continues to exist; and (v) the Executive terminates his employment within 30 days after the end of the Cure Period. If the Company
cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.

 

    3

     

    

 

(f)
Notice of Termination. Except for termination as specified in Section 3(a), any termination of the Executive’s
employment by the Company or any such termination by the Executive shall be communicated by written Notice of Termination to the
other party hereto. For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate
the specific termination provision in this Agreement relied upon.

 

(g)
Date of Termination. “Date of Termination” shall mean: (i) if the Executive’s employment is terminated
by his death, the date of his death; (ii) if the Executive’s employment is terminated on account of disability under Section
3(b) or by the Company for Cause under Section 3(c), the date on which Notice of Termination is given; (iii) if the Executive’s
employment is terminated by the Company under Section 3(d), the date on which a Notice of Termination is given or the date otherwise
specified by the Company in the Notice of Termination; and (iv) if the Executive’s employment is terminated by the Executive
under Section 3(e), 30 days after the date on which a Notice of Termination is given. Notwithstanding the foregoing, in the event
that the Executive gives a Notice of Termination to the Company, the Company may unilaterally accelerate the Date of Termination
and such acceleration shall not result in a termination by the Company for purposes of this Agreement.

 

4.
Termination Generally. If the Executive’s employment with the Company is terminated for any reason, the Company
shall pay or provide to the Executive (or to his authorized representative or estate) (i) any Base Salary earned through the Date
of Termination, unpaid expense reimbursements (subject to, and in accordance with, Section 2(c) of this Agreement) on or before
the time required by law but in no event more than 30 days after the Executive’s Date of Termination; and (ii) any vested
benefits the Executive may have under any employee benefit plan of the Company through the Date of Termination, which vested benefits
shall be paid and/or provided in accordance with the terms of such employee benefit plans (collectively, the “Accrued Benefit”).

 

5. Termination
by the Company without Cause or the Executive for Good Reason. During the Term, if the Executive’s employment is
terminated by the Company without Cause or by the Executive for Good Reason, then the Company shall pay the Executive his
Accrued Benefit. In addition, subject to the Executive (i) signing a separation agreement and release in a form and manner
satisfactory to the Company, which shall include, without limitation, a general release of claims in favor of the Company and
related persons and entities, a reaffirmation of the Executive’s post-employment obligations, and in the
Company’s sole discretion, a one year noncompetition agreement, and shall provide that, if the Executive breaches any
of the post,employment obligations, all payment of the Severance Amount shall immediately cease (the “Separation
Agreement and Release”), and (ii) the Separation Agreement and Release becoming irrevocable, all within 60 days after
the Date of Termination (or such period as set forth in the Separation Agreement and Release):

 

    4

     

    

 

(i)
the Company shall pay the Executive an amount equal to the sum of (i) nine (9) months of the Executive’s Base Salary
and (ii) pro rata portion of the Target Bonus earned by the Executive for the current calendar year measured from the first day
of such calendar year through the Date of Termination (the “Severance Amount”), provided in the event the Executive
is entitled to any payments pursuant to Section 8(h)(iii) below, the Severance Amount received in any calendar year will be reduced
by the amount the Executive is paid in the same such calendar year pursuant to the Section 8(h)(iii) below, (the “Restrictive
Covenants Agreement Setoff”); and

 

(ii)
subject to the Executive’s proper election to receive benefits under the Consolidated Omnibus Budget Reconciliation
Act of 1985, as amended (“COBRA”), the Company shall pay all amounts necessary to provide health insurance to the Executive
if the Executive had remained employed by the Company until the earliest of (A) the twelve (12) month anniversary of the Date of
Termination; (B) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical
plan; or (C) the cessation of the Executive’s continuation rights under COBRA; provided, however, if the Company determines
that it cannot pay such amounts without potentially violating applicable law (including, without limitation, Section 2716 of the
Public Health Service Act), then the Company will convert such payments to payroll payments directly to the Executive for the time
period specified above. Such payments shall be subject to tax-related deductions and withholdings and paid on the Company’s
regular payroll dates. For the avoidance of doubt, the taxable payments described above may be used for any purpose, including,
but not limited to, continuation coverage under COBRA.

 

The amounts payable under this Section 5(i) shall be paid out
in substantially equal installments in accordance with the Company’s payroll practice over twelve (12) months commencing
within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends
in a second calendar year, the Severance Amount shall begin to be paid in the second calendar year by the last day of such 60-day
period; provided, further, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately
following the Date of Termination. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes
of Treasury Regulation Section 1.409A-2(b)(2).

 

6.
Change in Control Payment. The provisions of this Section 6 set forth certain terms of an agreement reached between
the Executive and the Company regarding the Executive’s rights and obligations upon the occurrence of a Change in Control
of the Company. These provisions are intended to assure and encourage in advance the Executive’s continued attention and
dedication to his assigned duties and his objectivity during the pendency and after the occurrence of any such event. These provisions
shall apply in lieu of, and expressly supersede, the provisions of Section 5 regarding severance pay and benefits upon a termination
of employment, if such termination of employment occurs within 12 months after the occurrence of the first event constituting a
Change in Control (the “Change in Control Period”). These provisions shall terminate and be of no further force or
effect beginning after the Change in Control Period has ended.

 

(a)
Change in Control. During the Term, if during the Change in Control Period, the Executive’s employment is terminated
by the Company without Cause or by the Executive for Good Reason, then, subject to the signing of the Separation Agreement and
Release by the Executive and the Separation Agreement and Release becoming irrevocable, the time frame set forth in the Separation
Agreement and Release but in no event more than 60 days after the Date of Termination:

 

    5

     

    

 

(i)
the Company shall pay the Executive a lump sum in cash in an amount equal the sum of one times the sum of (A) the Executive’s
then current Base Salary (or the Executive’s Base Salary in effect immediately prior to the Change in Control, if higher)
plus (B) the Executive’s Target Bonus for the then-current year (the “Change in Control Payment”), provided the
Change in Control Payment shall be reduced by the amount of the Restrictive Covenants Agreement Setoff, if applicable, paid or
to be paid in the same calendar year; and

 

(ii)
notwithstanding anything to the contrary in any applicable option agreement or other stock-based award agreement, all stock
options and other stock-based awards subject to vesting held by the Executive (the “Equity Awards”) shall immediately
accelerate and become fully exercisable or nonforfeitable as of the later of (i) the Date of Termination or (ii) the Effective
Date of the Separation Agreement and Release (the “Accelerated Vesting Date”); provided that any termination
or forfeiture of the unvested portion of such Equity Awards that would otherwise occur on the Date of Termination in the absence
of this Agreement will be delayed until the Effective Date of the Separation Agreement and Release and will only occur if the vesting
pursuant to this subsection does not occur due to the absence of the Separation Agreement and Release becoming fully effective
within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of the Equity Awards shall occur
during the period between the Executive’s Date of Termination and the Accelerated Vesting Date; and

 

(iii)
subject to the Executive’s proper election to receive benefits under COBRA, the Company shall pay all amounts necessary
to provide health insurance to the Executive if the Executive had remained employed by the Company until the earliest of (A) the
twelve (12) month anniversary of the Date of Termination; (B) the Executive’s eligibility for group medical plan benefits
under any other employer’s group medical plan; or (C) the cessation of the Executive’s continuation rights under COBRA;
provided, however, if the Company determines that it cannot pay such amounts without potentially violating applicable law (including,
without limitation, Section 2716 of the Public Health Service Act), then the Company will convert such payments to payroll payments
directly to the Executive for the time period specified above. Such payments shall be subject to tax-related deductions and withholdings
and paid on the Company’s regular payroll dates. For the avoidance of doubt, the taxable payments described above may be
used for any purpose, including, but not limited to, continuation coverage under COBRA.

 

The amounts payable under this Section 6(a) shall be paid or
commence to be paid within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar
year and ends in a second calendar year, such payment shall be paid or commence to be paid in the second calendar year by the last
day of such 60-day period.

 

    6

     

    

 

(b)
Additional Limitation.

 

(i)
Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or
distribution by the Company to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant
to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 280G of the Code and the applicable
regulations thereunder (the “Aggregate Payments”), would be subject to the excise tax imposed by Section 4999 of the
Code, then the Aggregate Payments shall be reduced (but not below zero) so that the sum of all of the Aggregate Payments shall
be $1.00 less than the amount at which the Executive becomes subject to the excise tax imposed by Section 4999 of the Code; provided
that such reduction shall only occur if it would result in the Executive receiving a higher After Tax Amount (as defined below)
than the Executive would receive if the Aggregate Payments were not subject to such reduction. In such event, the Aggregate Payments
shall be reduced in the following order, in each case, in reverse chronological order beginning with the Aggregate Payments that
are to be paid the furthest in time from consummation of the transaction that is subject to Section 280G of the Code: (1) cash
payments not subject to Section 409A of the Code; (2) cash payments subject to Section 409A of the Code; (3) equity-based
payments and acceleration; and (4) non-cash forms of benefits; provided that in the case of all the foregoing Aggregate Payments
all amounts or payments that are not subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c) shall be reduced
before any amounts that are subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c).

 

(ii)
For purposes of this Section 6(b), the “After Tax Amount” means the amount of the Aggregate Payments less all
federal, state, and local income, excise and employment taxes imposed on the Executive as a result of the Executive’s receipt
of the Aggregate Payments. For purposes of determining the After Tax Amount, the Executive shall be deemed to pay federal income
taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination
is to be made, and state and local income taxes at the highest marginal rates of individual taxation in each applicable state and
locality, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes.

 

(iii)
The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section 6(b)(i) shall be
made by a nationally recognized accounting firm selected by the Company (the “Accounting Firm”), which shall provide
detailed supporting calculations both to the Company and the Executive within 15 business days of the Date of Termination, if applicable,
or at such earlier time as is reasonably requested by the Company or the Executive. Any determination by the Accounting Firm shall
be binding upon the Company and the Executive.

 

(c)
Definitions. For purposes of this Section 6, the following terms shall have the following meanings:

 

“Change in Control” shall have
the meaning of “Sale Event” as defined in the Company’s 2020 Stock Option and Incentive Plan, as amended, or
any successor plan.

 

    7

     

    

 

7.
Section 409A.

 

(a)
Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive’s separation from service
within the meaning of Section 409A of the Code, the Company determines that the Executive is a “specified employee”
within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive becomes
entitled to under this Agreement on account of the Executive’s separation from service would be considered deferred compensation
otherwise subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application
of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date
that is the earlier of (A) six months and one day after the Executive’s separation from service, or (B) the Executive’s
death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up
payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision,
and the balance of the installments shall be payable in accordance with his original schedule.

 

(b)
All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company
or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively
practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year
in which the expense was incurred. The amount of in-kind benefits provided, or reimbursable expenses incurred in one taxable year
shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except
for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits
is not subject to liquidation or exchange for another benefit.

 

(c)
To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation”
under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive’s termination
of employment, then such payments or benefits shall be payable only upon the Executive’s “separation from service.”
The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions
set forth in Treasury Regulation Section 1.409A-1(h).

 

(d)
The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that
any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in
such a manner so that all payments hereunder comply with Section 409A of the Code. Each payment pursuant to this Agreement is intended
to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). The parties agree that this Agreement
may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code
and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost
to either party.

 

(e)
The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any
provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not
satisfy an exemption from, or the conditions of, such Section.

 

    8

     

    

 

8.
Confidential Information, Assignment, Nonsolicitation and Noncompetition.

 

(a)
Proprietary Information. Executive agrees that all information, whether or not in writing, concerning the Company’s
business, technology, business relationships or financial affairs that the Company has not released to the general public (collectively,
“Proprietary Information”) and all tangible embodiments thereof are and will be the exclusive property of the
Company. By way of illustration, Proprietary Information may include information or material that has not been made generally available
to the public, such as: (a) corporate information, including plans, strategies, methods, policies, resolutions, negotiations
or litigation; (b) marketing information, including strategies, methods, client or business partner identities or other
information about customers or clients, business partners, prospect identities or other information about prospects, or market
analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure,
investors and holdings, purchasing and sales data and price lists; (d) operational and scientific information, including
plans, specifications, manuals, forms, templates, software, pre-clinical and clinical testing data and strategies, research and
development strategies, designs, methods, procedures, formulae, data, reports, discoveries, inventions, improvements, concepts,
ideas, and other Developments (as defined below), know-how and trade secrets; and (e) personnel information, including personnel
lists, reporting or organizational structure, resumes, personnel data, performance evaluations and termination arrangements or
documents. Proprietary Information also includes information received in confidence by the Company from its customers, suppliers,
business partners or other third parties.

 

(b)
Recognition of Company’s Rights. Executive will not, at any time, without the Company’s prior written
permission, either during or after his employment, disclose any Proprietary Information to anyone outside of the Company, or use
or permit to be used any Proprietary Information for any purpose other than the performance of Executive’s duties as an employee
of the Company. Executive will cooperate with the Company and use his best efforts to prevent the unauthorized disclosure of all
Proprietary Information. Executive will deliver to the Company all copies and other tangible embodiments of Proprietary Information
in his possession or control upon the earlier of a request by the Company or termination of Executive’s employment.

 

(c)
Rights of Others. Executive understands that the Company is now and may hereafter be subject to nondisclosure or
confidentiality agreements with third persons that require the Company to protect or refrain from use or disclosure of proprietary
information. Executive agrees to be bound by the terms of such agreements in the event Executive has access to such proprietary
information. Executive understands that the Company strictly prohibits Executive from using or disclosing confidential or proprietary
information belonging to any other person or entity (including any employer or former employer), in connection with Executive’s
employment. In addition, Executive agrees not to bring any confidential information belonging to any other person or entity onto
Company premises or into Company workspaces.

 

    9

     

    

 

(d)
Commitment to Company; Avoidance of Conflict of Interest. While an employee of the Company, Executive will devote
his full-time efforts to the Company’s business and Executive will not, directly or indirectly, engage in any other business
activity, except as expressly authorized in writing and in advance by a duly authorized representative of the Company. Executive
will advise an authorized officer of the Company or his designee at such time as any activity of either the Company or another
business presents Executive with a conflict of interest or the appearance of a conflict of interest as an employee of the Company.
Executive will take whatever action is requested of them by the Company to resolve any conflict or appearance of conflict which
it finds to exist.

 

(e)
Developments. Executive will make full and prompt disclosure to the Company of all inventions, discoveries, designs,
developments, methods, modifications, improvements, processes, algorithms, data, databases, computer programs, research, formulae,
techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship, and other intellectual
property, including works-in-process (collectively “Developments”) whether or not patentable or copyrightable,
that are created, made, conceived or reduced to practice by Executive (alone or jointly with others) or under my direction during
the period of his employment. Executive acknowledges that all work performed by them is on a “work for hire” basis,
and Executive hereby does assign and transfer and, to the extent any such assignment cannot be made at present, will assign and
transfer, to the Company and its successors and assigns all his right, title and interest in and to all Developments that (a) relate
to the business of the Company or any customer of, supplier to or business partner of the Company or any of the products or services
being researched, developed, manufactured or sold by the Company or which may be used with such products or services; or (b) result
from tasks assigned to them by the Company; or (c) result from the use of premises or personal property (whether tangible or intangible)
owned, leased or contracted for by the Company (“Company-Related Developments”), and all related patents, patent
applications, trademarks and trademark applications, copyrights and copyright applications, sui generis database rights
and other intellectual property rights in all countries and territories worldwide and under any international conventions (“Intellectual
Property Rights”).

 

To preclude any possible uncertainty, if there are any Developments
that Executive has, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of his
employment with the Company that Executive considers to be his property or the property of third parties and that Executive wishes
to have excluded from the scope of this Agreement (“Prior Inventions”), Executive has set forth on Exhibit
A attached hereto a complete list of those Prior Inventions. If disclosure of any such Prior Invention would cause them to
violate any prior confidentiality agreement, Executive understands that Executive is not to list such Prior Inventions in Exhibit
A but is only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that
full disclosure as to such inventions has not been made for that reason. If there are any patents or patent applications in which
Executive is named as an inventor, other than those that have been assigned to the Company (“Other Patent Rights”),
Executive has also listed those Other Patent Rights on Exhibit A. If no such disclosure is attached, Executive represents that
there are no Prior Inventions or Other Patent Rights. If, in the course of his employment with the Company, Executive incorporates
a Prior Invention into a Company product, process or machine, research or development program, or other work done for the Company,
Executive hereby grants to the Company a nonexclusive, royalty-free, fully paid- up, irrevocable, worldwide license (with the full
right to sublicense through multiple tiers) to make, have made, modify, use, sell, offer for sale and import such Prior Invention.

 

    10

     

    

 

Notwithstanding the foregoing, Executive will not incorporate,
or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company’s prior written consent.

 

This Agreement does not obligate Executive to assign to the
Company any Development that, in the sole judgment of the Company, reasonably exercised, is developed entirely on Executive’s
own time and does not relate to the business efforts or research and development efforts in which, during the period of his employment,
the Company actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned
or leased by the Company. However, Executive will also promptly disclose to the Company any such Developments for the purpose of
determining whether they qualify for such exclusion. Executive understands that to the extent this Agreement is required to be
construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes
of inventions made by an employee, this Section 8(e) will be interpreted not to apply to any invention that a court rules and/or
the Company agrees falls within such classes. Executive also hereby waives all claims to any moral rights or other special rights
that Executive may have or accrue in any Company-Related Developments.

 

(f)
Documents and Other Materials. Executive will keep and maintain adequate and current records of all Proprietary Information
and Company-Related Developments developed by them during his employment, which records will be available to and remain the sole
property of the Company at all times.

 

All files, letters, notes, memoranda, reports, records, data,
sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints, models, prototypes,
or other written, photographic or other tangible material containing Proprietary Information, whether created by them or others,
which come into his custody or possession, are the exclusive property of the Company to be used by them only in the performance
of his duties for the Company. Any property situated on the Company’s premises and owned by the Company, including without
limitation computers, disks and other storage media, filing cabinets or other work areas, is subject to inspection by the Company
at any time with or without notice. In the event of the termination of his employment for any reason, Executive will deliver to
the Company all Company property and equipment in his possession, custody or control, including all files, letters, notes, memoranda,
reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints,
models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, and other materials
of any nature pertaining to the Proprietary Information of the Company and to my work, and will not take or keep in his possession
any of the foregoing or any copies.

 

(g)
Enforcement of Intellectual Property Rights. Executive will cooperate fully with the Company, both during and after
his employment with the Company, with respect to the procurement, maintenance and enforcement of Intellectual Property Rights in
Company- Related Developments. Executive will sign, both during and after his employment, all papers, including without limitation
copyright applications, patent applications, declarations, oaths, assignments of priority rights, and powers of attorney, which
the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development or
Intellectual Property Rights therein. If the Company is unable, after reasonable effort, to secure his signature on any such papers,
Executive hereby irrevocably designates and appoints each officer of the Company as his agent and attorney-in-fact to execute any
such papers on his behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its
rights and interests in any Company-Related Development, including any Intellectual Property Rights therein.

 

    11

     

    

 

(h)
Nonsolicitation and Noncompetition. In order to protect the Company’s Proprietary Information and goodwill,
during his employment and for a period of: (i) one (1) year following the Date of Termination, or (ii) two (2) years following
the Date of Termination if Executive breaches his fiduciary duty to the Company or if Executive has unlawfully taken, physically
or electronically, property belonging to the Company (in either case the “Restricted Period”):

 

(i)
Executive shall not, directly or indirectly, in any manner, other than for the benefit of the Company, solicit or transact
any business with any of the customers or customer prospects of the Company or any of its suppliers. For purposes of this Agreement,
(x) business shall include any business that researches, develops, manufactures, markets, sells or distributes a product or service
that competes with a product or service of the Company, (y) customers shall include then current customers to which the Company
provided products or services during the 12 months prior to the Date of Termination (the “One Year Lookback”)
and customer prospects shall include customer prospects that the Company solicited during the One Year Lookback and that Executive
had significant contact with or learned confidential information about in the course of his employment, and (z) suppliers shall
include then current suppliers and suppliers that provided services to or in connection with the Company during the One Year Lookback.

 

(ii)
 Executive shall not, directly or indirectly, in any manner, solicit, entice or attempt to persuade any employee or consultant
of the Company to leave the Company for any reason or otherwise participate in or facilitate the hire, directly or through another
entity, of any person who is then employed or engaged by the Company.

 

(iii)
Unless (y) the Company terminates Executive’s employment without Cause (as defined below) or Executive has been laid
off; or (z) the Company waives the restrictions upon post-employment activities set forth in this Section 8(h)(iii), then, the
Company shall make garden leave payments to Executive for the postemployment portion of the Restricted Period (but for not more
than 12 months following the end of Executive’s employment) at the rate of 50% of the highest annualized base salary paid
to Executive by the Company within the two-year period preceding the last day of Executive’s employment (“Garden
Leave Pay”), and in exchange, Executive shall not directly or indirectly, whether as owner, partner, shareholder, director,
manager, consultant, agent, employee, co-venturer or otherwise, anywhere in the world, engage or otherwise participate in any business
that develops, manufactures or markets any products, or performs any services, that are competitive with the products or services
of the Company, including, without limitation, any products or services that target amino acid homeostasis for therapeutic and
health purposes via the use of amino acid modalities; or products or services that the Company or its affiliates, has under development
or that are the subject of active planning at any time during his employment. For purposes of this Section 8(h)(iii) only, and
notwithstanding anything to the contrary in any other part of this Agreement or any other agreement between the Company and Executive,
“Cause” shall mean a reasonable and good faith basis for the Company to be dissatisfied with Executive job performance,
Executive’s conduct or Executive’s behavior. Executive acknowledges that this covenant is necessary because the Company’s
legitimate business interests cannot be adequately protected solely by the other covenants in this Agreement. Executive further
acknowledges and agrees that any payments Executive receives pursuant to this Section 8(h)(iii) shall reduce (and shall not be
in addition to) any severance or separation pay that they are otherwise entitled to receive from the Company pursuant to this Agreement
or otherwise.

 

    12

     

    

 

9.
Litigation and Regulatory Cooperation. During and after the Executive’s employment, the Executive shall cooperate
fully with the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the future
against or on behalf of the Company which relate to events or occurrences that transpired while the Executive was employed by the
Company. The Executive’s full cooperation in connection with such claims or actions shall include, but not be limited to,
being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually
convenient times. During and after the Executive’s employment, the Executive also shall cooperate fully with the Company
in connection with any investigation or review of any federal, state or local regulatory authority as any such investigation or
review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company shall reimburse
the Executive for any reasonable out-of-pocket expenses incurred in connection with the Executive’s performance of obligations
pursuant to this Section 9.

 

10.
Government Contracts. Executive acknowledges that the Company may have from time to time agreements with other persons
or with the United States Government or its agencies that impose obligations or restrictions on the Company regarding inventions
made during the course of work under such agreements or regarding the confidential nature of such work. Executive agrees to comply
with any such obligations or restrictions upon the direction of the Company. In addition to the rights assigned under Section 8(e),
Executive also assigns to the Company (or any of its nominees) all rights that Executive has or acquired in any Developments, full
title to which is required to be in the United States under any contract between the Company and the United States or any of its
agencies.

 

11.
Prior Agreements. Executive hereby represents that, except as Executive has fully disclosed previously in writing
to the Company, Executive is not bound by the terms of any agreement with any previous or current employer or other party to refrain
from using or disclosing any trade secret or confidential or proprietary information in the course of his employment with the Company
or to refrain from competing, directly or indirectly, with the business of such employer or any other party. Executive further
represents that his performance of all the terms of this Agreement as an employee of the Company does not and will not breach any
agreement to keep in confidence proprietary information, knowledge or data acquired by them in confidence or in trust prior to
Executive’s employment with the Company. Executive will not disclose to the Company or induce the Company to use any confidential
or proprietary information or material belonging to any previous employer or others.

 

    13

     

    

 

12.
Remedies Upon Breach. Executive understands that the restrictions contained in Sections 8 and 9 of this Agreement
(collectively, the “Continuing Obligations”) are necessary for the protection of the business and goodwill of the Company
and Executive considers them to be reasonable for such purpose. Any breach of the Continuing Obligations is likely to cause the
Company substantial and irrevocable damage and therefore, in the event of such breach, the Company, in addition to such other remedies
which may be available, will be entitled to specific performance and other injunctive relief, without the posting of a bond. Executive
further acknowledges that a court may render an award extending the Restricted Period as one of the remedies in the event of his
violation of the Continuing Obligations. If Executive violates the Continuing Obligations, in addition to all other remedies available
to the Company at law (including, without limitation, the Company’s right to discontinue any payments Executive may receive
pursuant to this Agreement), in equity, and under contract, Executive agrees that Executive is obligated to pay all the Company’s
costs of enforcement of this Agreement, including reasonable attorneys’ fees and expenses.

 

13.
Use of Voice, Image and Likeness. Executive gives the Company permission to use any and all of his voice, image and
likeness, with or without using his name, in connection with the products and/or services of the Company, for the purposes of advertising
and promoting such products and/or services and/or the Company, and/or for other purposes deemed appropriate by the Company in
its reasonable discretion, except to the extent prohibited by law.

 

14.
No Employment Obligation. Executive understands that this Agreement does not create an obligation on the Company
or any other person to continue his employment. Executive acknowledges that, unless otherwise agreed in a formal written employment
agreement signed on behalf of the Company by an authorized officer, his employment with the Company is at will and therefore may
be terminated by the Company or Executive at any time and for any reason, with or without cause.

 

15.
Survival and Assignment by the Company. Executive understands that the Continuing Obligations will continue in accordance
with his express terms regardless of any changes in Executive’s title, position, duties, salary, compensation or benefits
or other terms and conditions of employment. Executive further understands that the Continuing Obligations will continue following
the termination of his employment regardless of the manner of such termination and will be binding upon his heirs, executors and
administrators. The Company will have the right to assign this Agreement to its affiliates, successors and assigns. Executive expressly
consents to be bound by the provisions of this Agreement for the benefit of the Company or any parent, subsidiary or affiliate
to whose employ Executive may be transferred without the necessity that this Agreement be resigned at the time of such transfer.

 

16.
Notice of Resignation. If Executive elects to resign from his employment with the Company, Executive agrees to provide
the Company with written notification of his resignation at least thirty (30) days prior to his intended resignation date. Such
notice shall include information in reasonable detail about his post-employment job duties and other business activities, including
the name and address of any subsequent employer and/or person or entity with whom or which Executive intends to engage in business
activities during the Restricted Period and the nature of his job duties and other business activities. The Company may elect to
waive all or part of the notice period in its sole discretion.

 

    14

     

    

 

17.
Post-Employment Notifications. During the Restricted Period, Executive will notify the Company of any change in his
address and of each subsequent employment or business activity, including the name and address of his employer or other post-Company
employment plans and the nature of his activities.

 

18.
Disclosures During Restricted Period. Executive will provide a copy of this Agreement with all compensation terms
redacted to any person or entity with whom Executive may enter into a business relationship, whether as an employee, consultant,
partner, coventurer or otherwise, prior to entering into such business relationship during the Restricted Period only.

 

19.
Waiver. The Company and Executive acknowledge and agree that the Company’s election not to provide Executive
with Garden Leave Pay as set forth in Section 8(h)(iii) shall be deemed a waiver of Executive’s noncompetition obligations
under Section 8(h)(iii). Otherwise, no waiver of any of Executive’s obligations under this Agreement shall be effective unless
made in writing by the Company. The failure of the Company to require Executive’s performance of any term or obligation of
this Agreement, or the waiver of any breach of this Agreement, shall not prevent the Company’s subsequent enforcement of
such term or obligation or be deemed a waiver of any subsequent breach.

 

20.
Severability. In case any provisions (or portions thereof) contained in this Agreement shall, for any reason, be
held invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other
provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had
never been contained herein. If, moreover, any one or more of the provisions contained in this Agreement shall for any reason be
held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing
it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear.

 

21.
Choice of Law and Jurisdiction. This Agreement will be deemed to be made and entered into in the Commonwealth of
Massachusetts, and will in all respects be interpreted, enforced and governed under the laws of the Commonwealth of Massachusetts.
Executive hereby consents to personal jurisdiction of the state and federal courts situated within Massachusetts for purposes of
enforcing this Agreement, and waive any objection that Executive might have to personal jurisdiction or venue in those courts,
provided, however, the Company and Executive agree that all civil actions relating to Section 8 of this Agreement shall be brought
in the county of Suffolk and that the superior court or the business litigation session of the superior court shall have exclusive
jurisdiction. ANY ACTION, DEMAND, CLAIM OR COUNTERCLAIM ARISING UNDER OR RELATING TO THIS AGREEMENT OR THE EXECUTIVE’S
EMPLOYMENT WITH THE COMPANY, INCLUDING WITHOUT LIMITATION ANY CLAIMS OF DISCRIMINATION ARISING UNDER STATE OR FEDERAL LAW, WILL
BE RESOLVED BY A JUDGE ALONE AND EACH OF THE COMPANY AND THE EXECUTIVE WAIVES ANY RIGHT TO A JURY TRIAL THEREOF.

 

    15

     

    

 

22.
Independence of Obligations. Executive’s obligations under this Agreement are independent of any obligation,
contractual or otherwise, the Company has to Executive. The Company’s breach of any such obligation shall not be a defense
against the enforcement of this Agreement or otherwise limit Executive’s obligations under this Agreement.

 

23.
Protected Disclosures. Executive understands that nothing contained in this Agreement limits his ability to communicate
with any federal, state or local governmental agency or commission, including to provide documents or other information, without
notice to the Company. Executive also understands that nothing in this Agreement limits his ability to share compensation information
concerning them or others, except that this does not permit Executive to disclose compensation information concerning others that
Executive obtains because his job responsibilities require or allow access to such information.

 

24.
Defend Trade Secrets Act of 2016. Executive understands that pursuant to the federal Defend Trade Secrets Act of
2016, Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of
a trade secret that (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly,
or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in
a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

 

25.
Successor to the Executive. This Agreement shall inure to the benefit of and be enforceable by the Executive’s
personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of the Executive’s
death after his termination of employment but prior to the completion by the Company of all payments due them under this Agreement,
the Company shall continue such payments to the Executive’s beneficiary designated in writing to the Company prior to his
death (or to his estate, if the Executive fails to make such designation).

 

26.
Successor to Company. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation
or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and agree to perform this
Agreement to the same extent that the Company would be required to perform it if no succession had taken place. Failure of the
Company to obtain an assumption of this Agreement at or prior to the effectiveness of any succession shall be a material breach
of this Agreement.

 

27.
Notices. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient
if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified
mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the
Company or, in the case of the Company, at its main offices, attention of the Board.

 

    16

     

    

 

28.
Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall be taken to be an original; but such counterparts shall together constitute one and the same document.

 

29.
Gender Neutral. Wherever used herein, a pronoun in the masculine gender shall be considered as including the feminine
gender unless the context clearly indicates otherwise.

 

30.
Entire Agreement; Amendment. This Agreement constitutes the entire agreement between the Company and Executive with
respect to the subject matter hereof, and supersedes all prior agreements or understandings, both written and oral, between the
Company and Executive with respect to the subject matter hereof, including without limitation the offer between the Company and
Executive, dated as of November 28, 2017, as amended, but does not in any way merge with or supersede any other confidentiality,
assignment of inventions or other restrictive covenant agreement or obligation entered into by the Company and Executive, which
agreements and obligations shall supplement, and shall not limit or be limited by, this Agreement. This Agreement may be amended
only in a written agreement executed by a duly authorized officer of the Company and Executive.

 

    17

     

    

 

IN WITNESS WHEREOF, the parties have executed
this Agreement effective on the date and year first above written.

 

 

	 	GEMINI THERAPEUTICS, INC.
	 	 	 
	 	By:	/s/
    Jason Meyenburg
	 	 	Jason Meyenburg
	 	 	 
	 	Its:	President and Chief Executive Officer
	 	 	 
	 	/s/ Scott
    Lauder
	 	Scott Lauder

 

 

    18

     

    

 

EXHIBIT A

 

	To:	GEMINI THERAPEUTICS, INC. (“COMPANY”)	 
	 	 	 	 
	From:	   	 	 
	 	 	 	 
	Date:	   	 	 
	 	 	 	 
	SUBJECT: 	Prior Inventions	 	 

 

The following is a complete list of all
inventions or improvements relevant to the subject matter of my employment by the Company that have been made or conceived or first
reduced to practice by me alone or jointly with others prior to my engagement by the Company:

 

	☐	No inventions or improvements

 

	☐	See below:
	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

	☐	Additional sheets attached

 

The following is a list of all
patents and patent applications in which Executive has been named as an inventor:

 

	☐	None

 

	☐	See below:EX-4.2

 Exhibit 4.2 

EXECUTION VERSION 

ELECTRONIC ARTS INC. 

and 
 U.S. BANK NATIONAL
ASSOCIATION, 
 as Trustee 
  

 
 1.850% Senior
Notes due 2031 
 2.950% Senior Notes due 2051 
  

 
 Second
Supplemental Indenture 
 Dated as of February 11, 2021 

to 
 Indenture dated as
of February 24, 2016 

 TABLE OF CONTENTS 

 

					
	 	  	PAGE	 
		
	ARTICLE 1	  	 	 
	DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION	  	 	 
		
	 Section 1.01 . Definitions
	  	 	1	 
	 Section 1.02 . Conflicts with Base Indenture
	  	 	9	 
		
	ARTICLE 2	  	 	 
	FORM OF NOTES	  	 	 
	 Section 2.01 . Form of Notes
	  	 	9	 
		
	ARTICLE 3	  	 	 
	THE NOTES	  	 	 
		
	 Section 3.01 . Amount; Series; Terms
	  	 	9	 
	 Section 3.02 . Denominations
	  	 	10	 
	 Section 3.03 . Book-entry Provisions for Global Securities
	  	 	10	 
	 Section 3.04 . Additional Notes; Repurchases
	  	 	11	 
	 Section 3.05 . No Sinking Fund
	  	 	12	 
		
	ARTICLE 4	  	 	 
	REDEMPTION OF SECURITIES	  	 	 
		
	 Section 4.01 . Optional Redemption
	  	 	12	 
	 Section 4.02 . Purchase of Notes upon a Change of Control Repurchase Event
	  	 	13	 
		
	ARTICLE 5	  	 	 
	COVENANTS AND REMEDIES	  	 	 
		
	 Section 5.01 . Limitation on Liens
	  	 	15	 
	 Section 5.02 . Limitation on Sale and Leaseback Transactions
	  	 	18	 
	 Section 5.03 . Events of Default
	  	 	19	 
	 Section 5.04 . Modification and Waiver
	  	 	20	 
	 Section 5.05 . References In Base Indenture
	  	 	21	 
	 Section 5.06 . Maintenance of Office or Agency
	  	 	21	 
	 Section 5.07 . Legal Holidays
	  	 	21	 
	 Section 5.08 . Defeasance and Discharge
	  	 	21	 
	 Section 5.09 No Additional Amounts. No Additional Amounts shall be payable with
respect to the Notes
	  	 	21	 
	 Section 5.10 SEC Reports. Section 3.4 of the Base Indenture shall not apply to
the Notes
	  	 	21	 

  
 i 

					
	ARTICLE 6	  	 	 
	MISCELLANEOUS	  	 	 
		
	 Section 6.01 . Confirmation of Indenture
	  	 	22	 
	 Section 6.02 . Counterparts
	  	 	22	 
	 Section 6.03 . Governing Law; Waiver of Jury Trial
	  	 	22	 
	 Section 6.04 . Recitals by the Company
	  	 	23	 
		
	 Exhibit A Form of 2031 Note
	  	 	A-1	 
	 Exhibit B Form of 2051 Note
	  	 	B-1	 

  

  
 ii 

 SECOND SUPPLEMENTAL INDENTURE, dated as of February 11, 2021 (“Second
Supplemental Indenture”), to the Indenture dated as of February 24, 2016 (as amended, modified or supplemented from time to time in accordance therewith, other than with respect to a particular Series of debt securities, the
“Base Indenture” and, as amended, modified and supplemented by this Second Supplemental Indenture, the “Indenture”), by and among ELECTRONIC ARTS INC., a Delaware corporation (the “Company”), and
U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”). 
 Each party agrees as follows
for the benefit of the other party and for the equal and ratable benefit of the Holders of the Notes: 
 WHEREAS, the Company has duly
authorized the execution and delivery of the Base Indenture to provide for the issuance from time to time of senior debt securities to be issued in one or more Series as provided in the Base Indenture; 

WHEREAS, the Company has duly authorized the execution and delivery, and desires and has requested the Trustee to join it in the execution and
delivery, of this Second Supplemental Indenture in order to establish and provide for the issuance by the Company of a Series of Securities designated as its 1.850% Senior Notes due 2031 (the “2031 Notes”) and a Series of Securities
designated as its 2.950% Senior Notes due 2051 (the “2051 Notes” and, together with the 2031 Notes, the “Notes”), on the terms set forth herein; 

WHEREAS, Section 8.1(h) of the Base Indenture provides that a supplemental indenture may be entered into by the parties for such purpose
without notice to or the consent of any Securityholder, provided certain conditions are met; 
 WHEREAS, the conditions set forth in
the Base Indenture for the execution and delivery of this Second Supplemental Indenture have been met; and 
 WHEREAS, all things necessary
to make this Second Supplemental Indenture a valid and binding agreement of the parties, in accordance with its terms, and a valid amendment of, and supplement to, the Base Indenture with respect to the Notes have been done; 

NOW, THEREFORE: 
 ARTICLE 1

 DEFINITIONS AND OTHER PROVISIONS OF GENERAL
APPLICATION 
 Section 1.01. Definitions. Capitalized terms used herein and
not otherwise defined herein have the meanings assigned to them in the Base Indenture. To the extent terms are defined in both this Second Supplemental Indenture and the Base Indenture, the applicable definition in this Second Supplemental Indenture
shall control. The words “herein,” “hereof” and “hereby” and other words of similar import used in this Second Supplemental Indenture refer to this Second Supplemental Indenture as a whole and not to any particular
section hereof. 

  
 1 

 As used herein, the following terms have the specified meanings: 

“2031 Notes” has the meaning specified in the recitals of this Second Supplemental Indenture. 

“2051 Notes” has the meaning specified in the recitals of this Second Supplemental Indenture. 

“Additional Notes” has the meaning specified in Section 3.04 of this Second Supplemental Indenture. 

“Agent Members” has the meaning specified in Section 3.03(f) of this Second Supplemental Indenture. 

“Attributable Debt” means, with respect to any sale and leaseback transaction, at the time of determination, the lesser of
(1) the fair market value of the Principal Property (as determined in good faith by the Board of Directors) subject to such transaction, and (2) the total obligation (discounted to the present value at the implicit interest factor,
determined in accordance with GAAP, included in the rental payments) of the lessee for rental payments (other than amounts required to be paid on account of property taxes as well as maintenance, repairs, insurance, water rates and other items which
do not constitute payments for property rights) during the remaining portion of the base term of the lease included in such transaction. In the case of any lease which is terminable by the lessee upon the payment of a penalty, such present value
shall be the lesser of (i) the present value determined assuming termination upon the first date such lease may be terminated (in which case the present value shall also include the amount of the penalty, but shall not include any rent that
would be required to be paid under such lease subsequent to the first date upon which it may be terminated) and (ii) the present value assuming no such termination. 

“Bankruptcy Law” means Title 11 of the United States Code or any similar federal or state law for the relief of debtors. 

“Base Indenture” has the meaning specified in the recitals of this Second Supplemental Indenture. 

“Business Day” when used with respect to any Note, means each Monday, Tuesday, Wednesday, Thursday and Friday which is not a
day on which banking institutions in New York, New York are authorized or obligated by law or executive order to close. 
 “Change
of Control” means the occurrence of any of the following: (1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or
substantially all of the assets of the Company and its Subsidiaries taken as a whole to any “person” (as that term is used in 

  
 2 

 
Section 13(d)(3) of the Exchange Act) other than to the Company or one of its Subsidiaries; (2) the adoption of a plan by the Board of Directors relating to the Company’s
liquidation or dissolution; (3) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any person becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the aggregate of the total voting power of the Company’s Voting Shares or other
Voting Shares into which the Company’s Voting Shares are reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares; provided, however, that a person shall not be deemed beneficial
owner of, or to own beneficially, (A) any securities tendered pursuant to a tender or exchange offer made by or on behalf of such person or any Affiliates of such person until such tendered securities are accepted for purchase or exchange
thereunder, or (B) any securities if such beneficial ownership (i) arises solely as a result of a revocable proxy delivered in response to a proxy or consent solicitation made pursuant to the applicable rules and regulations under the
Exchange Act, and (ii) is not also then reportable on Schedule 13D (or any successor schedule) under the Exchange Act; or (4) the Company consolidates with, or merges with or into, any person, or any person consolidates with, or merges
with or into, the Company, in any such event pursuant to a transaction in which any of the outstanding Voting Shares of the Company or such other person is converted into or exchanged for cash, securities or other Property, other than any such
transaction where the Company’s Voting Shares outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Shares (measured by voting power) of the surviving person or any direct
or indirect parent company of any surviving person immediately after giving effect to such transaction. 
 “Change of Control
Notice” has the meaning specified in Section 4.02(a) of this Second Supplemental Indenture. 
 “Change of Control
Offer” has the meaning specified in Section 4.02(a) of this Second Supplemental Indenture. 
 “Change of Control
Payment Date” has the meaning specified in Section 4.02(a) of this Second Supplemental Indenture. 
 “Change of
Control Repurchase Event” means the occurrence of both a Change of Control and a Ratings Event. 
 “Company” means
the party named as such in the recitals of this Second Supplemental Indenture until a successor replaces it pursuant to the terms and conditions of the Indenture and thereafter means the successor. 

“Comparable Treasury Issue” means the United States Treasury security selected by an Independent Investment Banker as having
an actual or interpolated maturity comparable to the remaining term of the applicable Notes to be redeemed pursuant to Section 4.01 of this Second Supplemental Indenture (assuming such Notes matured on the applicable Par Call Date) that would
be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes (assuming such Notes matured on the applicable
Par Call Date). 

  
 3 

 “Comparable Treasury Price” means, with respect to any Redemption Date
pursuant to Section 4.01 of this Second Supplemental Indenture, (1) if the Company obtains four or more applicable Reference Treasury Dealer Quotations, the arithmetic average of the applicable Reference Treasury Dealer Quotations for such
Redemption Date after excluding the highest and lowest such Reference Treasury Dealer Quotations, (2) if the Company obtains fewer than four and more than one applicable Reference Treasury Dealer Quotations, the arithmetic average of all
applicable Reference Treasury Dealer Quotations for such Redemption Date or (3) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Consolidated Total Assets” means, as of any date of determination, the total assets of the Company and its Subsidiaries on a
consolidated basis as shown on or reflected on the Company’s most recent internal consolidated balance sheet, including relevant footnotes thereto (without duplication), prepared in accordance with GAAP, after giving effect to any acquisitions
or dispositions occurring subsequent to the date of such balance sheet. 
 “Corporate Trust Office” means the designated
office of the Trustee at which at any time its corporate trust business shall be administered, which office at the date hereof is located at U.S. Bank National Association, 633 West Fifth Street, 24th Floor, Los Angeles, CA 90071, Attention: Global
Corporate Trust Services, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the designated corporate trust office of any successor trustee (or such other address as such successor
trustee may designate from time to time by notice to the Holders and the Company). 
 “Custodian” means any receiver,
trustee, assignee, liquidator or similar official under any Bankruptcy Law. 
 “delivered,” with respect to any notice to
be given to a Holder pursuant to the Indenture, shall mean notice (x) given to the Depository (or its designee) pursuant to the standing instructions from the Depository or its designee, including by electronic mail in accordance with accepted
practices or procedures at the Depository (in the case of a Global Security) or (y) mailed to such Holder by first class mail, postage prepaid, at its address as it appears on the Registrar’s books. Notice so “delivered” shall be
deemed to include any notice to be “mailed” or “given,” as applicable, under the Indenture 
 “Event of
Default” has the meaning specified in Section 5.03 of this Second Supplemental Indenture. 
 “Exchange Act”
means the Securities Exchange Act of 1934, as amended. 
 “GAAP” means generally accepted accounting principles in the
United States of America in effect from time to time. 

  
 4 

 “guarantee” means any obligation, contingent or otherwise, of any Person
directly or indirectly guaranteeing any Indebtedness of any other Person and any obligation, direct or indirect, contingent or otherwise, of such Person (1) to purchase or pay (or advance or supply funds for the purchase or payment of) such
Indebtedness of such other Person (whether arising by virtue of partnership arrangements, or by agreement to keep well, to purchase assets, goods, securities or services, to take or pay or to maintain financial statement conditions or otherwise) or
(2) entered into for purposes of assuring in any other manner the obligee of such Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); provided, however, that the
term “guarantee” shall not include endorsements for collection or deposit in the ordinary course of business. The term “guarantee,” when used as a verb, has a correlative meaning. 

“Hedging Obligations” means, with respect to any specified Person, the obligations of such Person under:
(1) interest rate swap agreements (whether from fixed to floating or from floating to fixed), interest rate cap agreements and interest rate collar agreements; (2) other agreements or arrangements designed to manage interest rates or
interest rate risk; and (3) other agreements or arrangements designed to protect such Person against fluctuations in currency exchange rates or commodity prices. 

“Indebtedness” means, with respect to any Person, indebtedness of such Person for borrowed money (including, without
limitation, indebtedness for borrowed money evidenced by notes, bonds, debentures or similar instruments but not including Non-recourse Obligations), if and to the extent any of the foregoing indebtedness
would appear as a liability upon an unconsolidated balance sheet of such Person (but does not include contingent liabilities which appear only in a footnote to a balance sheet). 

“Indenture” has the meaning specified in the recitals of this Second Supplemental Indenture. 

“Independent Investment Banker” means one of the Reference Treasury Dealers, as may be appointed from time to time by the
Company; provided, however, that if any Reference Treasury Dealer ceases to be a Primary Treasury Dealer, the Company shall substitute another Primary Treasury Dealer. 

“Initial 2031 Notes” has the meaning set forth in Section 3.01(b) of this Second Supplemental Indenture. 

“Initial 2051 Notes” has the meaning set forth in Section 3.01(b) of this Second Supplemental Indenture. 

“Initial Notes” has the meaning set forth in Section 3.01(b) of this Second Supplemental Indenture. 

  
 5 

 “Investment Grade” means a rating of Baa3 or better by Moody’s (or its
equivalent under any successor Rating Categories of Moody’s); a rating of BBB- or better by S&P (or its equivalent under any successor Rating Categories of S&P); or, if applicable, the equivalent
investment grade credit rating from any Substitute Rating Agency. 
 “Lien” means any mortgage, lien, pledge, charge, or
other security interest or encumbrance of any kind (including any conditional sale or other title retention agreement and any lease in the nature thereof). 

“Moody’s” means Moody’s Investors Service, Inc. and its successors. 

“Non-recourse Obligation” means Indebtedness or other obligations substantially
related to (1) the acquisition of assets not previously owned by the Company or any direct or indirect Subsidiaries of the Company or (2) the financing of a project involving the development or expansion of the Properties of the Company or
any direct or indirect Subsidiaries of the Company, as to which the obligee with respect to such Indebtedness or obligation has no recourse to the Company or any direct or indirect Subsidiary of the Company or such Subsidiary’s assets other
than the assets which were acquired with the proceeds of such transaction or the project financed with the proceeds of such transaction (and the proceeds thereof). 

“Notes” has the meaning specified in the recitals of this Second Supplemental Indenture. 

“Par Call Date” means with respect to the 2031 Notes, November 15, 2030, the date that is three months prior to the
Stated Maturity of the 2031 Notes and, with respect to the 2051 Notes, August 15, 2050, the date that is six months prior to the Stated Maturity of the 2051 Notes. 

“Primary Treasury Dealer” means a primary U.S. Government securities dealer in the United States of America. 

“Principal Property” means (1) those real properties (and adjacent facilities) of the Company and any of its Restricted
Subsidiaries located at each of 209 Redwood Shores Parkway, Redwood City, California, United States and 4330 Sanderson Way, Burnaby, British Columbia, Canada and (2) any building, structure or other facility, together with the land upon which
it is erected and any fixtures which are a part of the building, structure or other facility, located in the United States, and owned or leased or to be owned or leased by the Company or any of its Restricted Subsidiaries, and in each case the net
book value of which as of that date exceeds $50 million, other than any such land, building, structure or other facility or portion thereof which, in the opinion of the Board of Directors (or any committee thereof duly authorized to act on
behalf of such Board of Directors) by resolution determines in good faith not of material importance to the total business conducted by the Company and its Restricted Subsidiaries, considered as one enterprise. 

“Property” means any property or asset, whether real, personal or mixed, or tangible or intangible, including shares of
Capital Stock. 

  
 6 

 “Prospectus” means the preliminary prospectus supplement dated
February 9, 2021, including the base prospectus dated November 20, 2020 and as supplemented by the related pricing term sheet dated February 9, 2021, relating to the offering and sale of the Notes. 

“Rating Agency” means Moody’s and S&P; provided that if either Moody’s or S&P ceases to rate the
Notes or fails to make a rating of the applicable Series of Notes publicly available, “Rating Agency” shall include a Substitute Rating Agency appointed by the Company. 

“Rating Category” means (i) with respect to S&P, any of the following categories: AAA, AA, A, BBB, BB, B,
CCC, CC, C and D (or equivalent successor categories); (ii) with respect to Moody’s, any of the following categories: Aaa, Aa, A, Baa, Ba, B, Caa, Ca, C and D (or equivalent successor categories); and (iii) the equivalent of any such
category of S&P or Moody’s used by a Substitute Rating Agency. 
 “Ratings Event” means that the applicable Series
of Notes ceases to be rated Investment Grade by both Rating Agencies on any day during the Trigger Period. If either Rating Agency is not providing a rating of that Series of Notes on any day during the Trigger Period for any reason (subject, for
the avoidance of doubt, to the Company’s right to engage a Substitute Rating Agency as provided herein), the rating of such Rating Agency for such Series of Notes shall be deemed to have ceased to be Investment Grade during the Trigger Period.

 “Record Date” has the meaning specified in Section 3.01(d) of this Second Supplemental Indenture. 

“Reference Treasury Dealer” means each of J.P. Morgan Securities LLC, BofA Securities, Inc., each of their respective
successors, and any other Primary Treasury Dealers selected by the Company. 
 “Reference Treasury Dealer Quotations”
means, with respect to each Reference Treasury Dealer and any Redemption Date, the arithmetic average, as determined by the Independent Investment Banker, of the bid and asked prices for the applicable Comparable Treasury Issue (expressed in
each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker by such Reference Treasury Dealer as of 5:00 p.m., New York City time, on the third Business Day preceding such Redemption Date. 

“Remaining Scheduled Payments” means, with respect to any Note to be redeemed pursuant to Section 4.01 of this Second
Supplemental Indenture, the remaining scheduled payments of the principal thereof and interest thereon that would be due after the related Redemption Date but for such redemption calculated as if the Stated Maturity of such Note was the applicable
Par Call Date; provided, however, that if such Redemption Date is not an Interest Payment Date with respect to such Note, the amount of the next scheduled interest payment thereon shall be reduced by the amount of interest accrued
thereon to such Redemption Date. 
 “Restricted Subsidiary” means any domestic Subsidiary of the Company other than any of
the Company’s less than 80%-owned Subsidiaries if the common stock of such Subsidiary is traded on any national securities exchange or on the over-the-counter
markets. 

  
 7 

 “S&P” means Standard & Poor’s Ratings Services, a
division of The McGraw-Hill Companies, Inc. and its successors. 
 “Second Supplemental Indenture” has the meaning
specified in the recitals of this Second Supplemental Indenture. 
 “SEC” means the U.S. Securities and Exchange
Commission. 
 “Subsidiary” of any specified Person means any corporation, limited liability company, limited partnership,
association or other business entity of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at
the time owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof. 

“Substitute Rating Agency” means a “nationally recognized statistical rating organization” within the meaning of
Section 3(a)(62) of the Exchange Act, selected by the Company as a replacement agency for Moody’s or S&P, or both of them, as the case may be. 

“Treasury Rate” means, with respect to any Redemption Date pursuant to Section 4.01 of this Second Supplemental
Indenture, the rate per annum equal to the semi-annual equivalent yield to maturity (computed as of the third Business Day immediately preceding that Redemption Date) of the applicable Comparable Treasury Issue. In determining this rate, the
Independent Investment Banker shall assume a price for the applicable Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the applicable Comparable Treasury Price for such Redemption Date. 

“Trigger Period” means the period commencing on the earlier of (a) the first public notice of the occurrence of a Change
of Control or (b) the public announcement by the Company of its intention to effect a Change of Control, and ending 60 days following consummation of such Change of Control (which period shall be extended so long as the rating of the applicable
Series of Notes is under publicly announced consideration for a possible rating downgrade by any of the Rating Agencies on such 60th day, such extension to last with respect to each such Rating Agency until the date on which such Rating Agency
considering such possible downgrade either (x) rates the applicable Series of Notes below Investment Grade or (y) publicly announces that it is no longer considering the Notes for possible downgrade, provided that no such extension
shall occur if on such 60th day the applicable Series of Notes is rated Investment Grade by at least one of such Rating Agencies in question and is not subject to review for possible downgrade by such Rating Agency). 

“Trust Indenture Act” means the Trust Indenture Act of 1939 (15 U.S. Code Sections 77aaa-77bbbb), as amended. 

“Voting Shares” of any specified “person” (as that term is used in Section 13(d)(3) of the Exchange Act) as of
any date means the Capital Stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person. 

  
 8 

 Section 1.02. Conflicts with Base Indenture.
In the event that any provision of this Second Supplemental Indenture limits, qualifies or conflicts with a provision of the Base Indenture, such provision of this Second Supplemental Indenture shall control. 

ARTICLE 2 

FORM OF NOTES 

Section 2.01. Form of Notes. The 2031 Notes shall be substantially in the form of Exhibit A
hereto and the 2051 Notes shall be substantially in the form of Exhibit B hereto, both of which are hereby incorporated in and expressly made a part of the Indenture. 

ARTICLE 3 

THE NOTES 

Section 3.01. Amount; Series; Terms. (a) There is hereby created and designated two
Series of Securities under the Base Indenture: the title of the 2031 Notes shall be “1.850% Senior Notes due 2031,” and the title of the 2051 Notes shall be “2.950% Senior Notes due 2051.” The changes, modifications and
supplements to the Base Indenture effected by this Second Supplemental Indenture shall be applicable only with respect to, and govern the terms of, the Notes and shall not apply to any other Series of Securities that may be issued under the Base
Indenture unless a supplemental indenture with respect to such other Series of Securities specifically incorporates such changes, modifications and supplements. 

(b) The aggregate principal amount of 2031 Notes that initially may be authenticated and delivered under this Second Supplemental Indenture
(the “Initial 2031 Notes”) shall be limited to $750,000,000, and the aggregate principal amount of 2051 Notes that initially may be authenticated and delivered under this Second Supplemental Indenture (the “Initial 2051
Notes” and, together with the Initial 2031 Notes, the “Initial Notes”) shall be limited to $750,000,000, subject, in each case, to increase as set forth in Section 3.04 of this Second Supplemental
Indenture. 
 (c) The Stated Maturity of the 2031 Notes shall be February 15, 2031 and the Stated Maturity of the 2051 Notes shall be
February 15, 2051. The Notes shall be payable and may be presented for payment, purchase, redemption, registration of transfer and exchange, without service charge (subject to Section 2.7 of the Base Indenture), at the office or agency of
the Company maintained for such purpose, which shall initially be the Corporate Trust Office. 
 (d) The 2031 Notes shall bear interest at
the rate of 1.850% per annum and the 2051 Notes shall bear interest at the rate of 2.950% per annum, in each case beginning on February 11, 2021 or from the most recent Interest Payment Date to or for which interest has been paid or duly
provided for, as further provided in the form of 2031 Note annexed hereto as Exhibit A and form of 2051 Note annexed hereto as Exhibit B. Interest shall be computed on the basis of a 360-day

  
 9 

 
year consisting of twelve 30-day months. The Interest Payment Dates for the Notes shall be February 15 and August 15 of each year, beginning on
August 15, 2021, and the “Record Date” for any interest payable on each such Interest Payment Date shall be the immediately preceding February 1 and August 1, respectively; provided that upon the Stated
Maturity of each Series of Notes interest shall be payable on such Stated Maturity from the most recent date to which interest has been paid or duly provided, and shall include the required payment of principal or premium, if any; and
provided further, the “Record Date” for any interest, principal, or premium, if any, payable on the Stated Maturity of each Series of Notes shall be the immediately preceding February 1. If any Interest Payment Date,
Stated Maturity or other payment date with respect to the Notes is not a Business Day, the required payment of principal, premium, if any, or interest shall be due on the next succeeding Business Day as if made on the date that such payment was due,
and no interest shall accrue on that payment for the period from and after that Interest Payment Date, Stated Maturity or other payment date, as the case may be, to the date of that payment on the next succeeding Business Day. 

(e) The Notes of each Series shall be issued in the form of one or more Global Securities, deposited with the Trustee as custodian for the
Depository or its nominee, duly executed by the Company and authenticated by the Trustee as provided in Section 3.03 of this Second Supplemental Indenture and the Base Indenture. 

(f) Payment of principal of and premium, if any, and interest on a Global Security registered in the name of or held by the Depository or its
nominee shall be made in immediately available funds to the Depository or its nominee, as the case may be, as the registered Holder of such Global Security. If the Notes of a Series are no longer represented by a Global Security, payment of
principal, premium, if any, and interest on certificated Notes of such Series in definitive form may, at the Company’s option, be made by (i) check mailed directly to Holders at their registered addresses or (ii) upon request of any
Holder of at least $5,000,000 principal amount of Notes of such Series, wire transfer to an account located in the United States of America maintained by the payee. 

Section 3.02. Denominations. The Notes of each Series shall be issuable only in registered
form without coupons and only in denominations of $2,000 and any multiple of $1,000 in excess thereof. 

Section 3.03. Book-entry Provisions for Global Securities. (a) Each Global Security
authenticated under the Indenture shall be registered in the name of the Depository designated for such Global Security or a nominee thereof and delivered to such Depository or nominee thereof or custodian therefor. Each such Global Security shall
constitute a single Security for all purposes of the Indenture. 
 (b) Subject to Section 2.7 of the Base Indenture, any exchange of a
Global Security for other Notes may be made in whole or in part, and all Notes issued in exchange for a Global Security or any portion thereof shall be registered in such names as the Depository for such Global Security shall direct in writing to
the Trustee. 

  
 10 

 (c) Every Note authenticated and delivered upon registration of transfer of, or in exchange
for or in lieu of, a Global Security or any portion thereof shall be authenticated and delivered in the form of, and shall be, a Global Security, unless such Note is registered in the name of a Person other than the Depository for such Global
Security or a nominee thereof. 
 (d) Subject to the provisions of Section 3.03(f) below, the registered Holder may grant proxies and
otherwise authorize any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under the Indenture or the Notes. 

(e) In the event of the occurrence of any of the events specified in the fifth and sixth paragraphs of Section 2.7 of the Base Indenture,
the Company will promptly make available to the Trustee a reasonable supply of certificated Notes in definitive, fully registered form, without interest coupons, with such reasonable adjustments, if any, to the forms of 2031 Note and 2051 Note set
forth in Exhibit A and Exhibit B hereto, respectively, as may be necessary or advisable to reflect that such definitive Notes are not Global Securities. 

(f) Neither any members of, or participants in, the Depository (collectively, the “Agent Members”) nor any other Persons on
whose behalf Agent Members may act shall have any rights under the Indenture with respect to any Global Security registered in the name of the Depository or any nominee thereof, or under any such Global Security, and the Depository or such nominee,
as the case may be, may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner and holder of such Global Security for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall
prevent the Company or the Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depository or such nominee, as the case may be, or impair, as between the
Depository, its Agent Members and any other Person on whose behalf an Agent Member may act, the operation of customary practices of such Persons governing the exercise of the rights of a Holder of any Note. 

Section 3.04. Additional Notes; Repurchases. The Company may, from time to time, subject to
compliance with any other applicable provisions of the Indenture, without notice to or the consent of the Holders of the Notes, create and issue pursuant to the Indenture additional 2031 Notes or additional 2051 Notes (together, the
“Additional Notes”) having terms and conditions identical to those of the Initial 2031 Notes or the Initial 2051 Notes, as applicable, and ranking equally and ratably with the Initial 2031 Notes or the Initial 2051 Notes, as
applicable, except that Additional Notes of a Series: 
 (i) may have a different issue date from the Initial 2031 Notes or
the Initial 2051 Notes, as applicable; 
 (ii) may have a different issue price from the Initial 2031 Notes or the Initial
2051 Notes, as applicable; and 

  
 11 

 (iii) may have a different amount of interest payable on the first Interest
Payment Date after issuance than is payable on the Initial 2031 Notes or the Initial 2051 Notes, as applicable; 
 provided that if such Additional
Notes are not fungible with the outstanding Notes of the applicable Series for U.S. federal income tax purposes, such Additional Notes shall have one or more separate CUSIP numbers. Such Additional Notes may be consolidated and form a single series
with, and shall have the same terms as to ranking, redemption, waivers, amendments or otherwise, as the Initial 2031 Notes or the Initial 2051 Notes, as applicable, and shall vote together as one class on all matters with respect to the 2031 Notes
or the 2051 Notes, as the case may be. 
 The Company may, to the extent permitted by law, and directly or indirectly (regardless of whether such Notes are
surrendered to the Company), purchase Notes in the open market or otherwise, whether by the Company or its Subsidiaries or through a private or public tender or exchange offer or through counterparties to private agreements, including by
cash-settled swaps or other derivatives. The Company shall cause any Notes so purchased (other than Notes purchased pursuant to cash-settled swaps or other derivatives) to be surrendered to the Trustee for cancellation, and such Notes shall no
longer be considered outstanding under the Indenture upon their purchase. 
 Section 3.05. No
Sinking Fund. The Notes shall not be subject to any sinking fund. 
 ARTICLE 4 

REDEMPTION OF SECURITIES 

Section 4.01. Optional Redemption. (a) Subject to Section 1.02 hereof, the
provisions of Article IX of the Base Indenture, as supplemented by the provisions of this Second Supplemental Indenture, shall apply to the Notes. 

(b) At any time before November 15, 2030, in the case of the 2031 Notes, or before August 15, 2050, in the case of the 2051 Notes,
Notes of such Series shall be redeemable, as a whole at any time or from time to time in part, at the Company’s option, at a Redemption Price equal to the greater of (i) 100% of the aggregate principal amount of the applicable Notes to be
redeemed and (ii) the sum of the present value of the Remaining Scheduled Payments of such Notes, less accrued and unpaid interest thereon to, but excluding, the Redemption Date for such Notes, discounted to the Redemption Date on a semi-annual
basis (assuming a 360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate plus 12.5 basis points, in the case of the 2031
Notes, and 15.0 basis points, in the case of the 2051 Notes, plus in each case, accrued and unpaid interest thereon to, but excluding, the Redemption Date for such Notes. 

(c) On or after November 15, 2030, in the case of the 2031 Notes, or on or after August 15, 2050, in the case of the 2051 Notes,
Notes of such Series shall be redeemable, as a whole at any time or from time to time in part, at the Company’s option, at a Redemption Price equal to 100% of the aggregate principal amount of the applicable Notes to be redeemed, plus in each
case, accrued and unpaid interest thereon to, but excluding, the Redemption Date for such Notes. 

  
 12 

 (d) Notwithstanding Section 4.01(b) and Section 4.01(c) above, installments of
interest on Notes that are due and payable on Interest Payment Dates falling on or prior to a Redemption Date shall be payable on the Interest Payment Date to the registered Holders as of the close of business on the relevant Record Date in
accordance with the provisions of such Notes and the Indenture. 
 (e) On and after the Redemption Date for a Series of Notes, interest
shall cease to accrue on such Notes or any portion thereof called for redemption, unless the Company defaults in the payment of the Redemption Price and accrued interest, if any. If less than all of the Notes of the applicable Series are to be
redeemed, the Notes of a Series to be redeemed shall be selected pro rata or by lot and, in the case of Notes represented by a Global Security, in accordance with the procedures of the Depository; provided, however, that in no event
shall Notes of a principal amount of $2,000 or less be redeemed in part. 
 (f) Notice of any redemption shall be delivered at least
10 days but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed. Such notice shall state the Redemption Price (if known) or the formula pursuant to which the Redemption Price is to be determined if
the Redemption Price cannot be determined at the time the notice is given. If the Redemption Price cannot be determined at the time such notice is to be given, the actual Redemption Price, calculated as described above in Section 4.01(b) or
Section 4.01(c), as applicable, shall be set forth in an Officers’ Certificate delivered to the Trustee no later than two Business Days prior to the Redemption Date. Notice of redemption having been given as provided in the Indenture, the
Notes called for redemption shall become due and payable on the Redemption Date and at the applicable Redemption Price, plus accrued and unpaid interest, if any, to, but excluding, the Redemption Date. A notice of redemption may, at the
Company’s option and discretion, be subject to one or more conditions precedent. 

Section 4.02. Purchase of Notes upon a Change of Control Repurchase Event. (a) If a
Change of Control Repurchase Event occurs with respect to a Series of Notes, unless the Company shall have exercised its option to redeem the Notes of such Series pursuant to Section 4.01 of this Second Supplemental Indenture, each Holder of
the Notes of such Series shall have the right to require the Company to repurchase all or any part (equal to $2,000 and multiples of $1,000 in excess thereof) of that Holder’s Notes of such Series at a repurchase price in cash equal to 101% of
the aggregate principal amount of the Notes to be repurchased plus any accrued and unpaid interest on such Notes to, but excluding, the repurchase date. Within 30 days following any Change of Control Repurchase Event with respect to a Series of
Notes or, at the option of the Company, prior to any Change of Control, but after the public announcement of the Change of Control or event that may constitute the Change of Control, the Company shall deliver a notice (the “Change of Control
Notice”) to each Holder of such Notes, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering (the “Change of Control
Offer”) to repurchase such Notes on the repurchase date 

  
 13 

 
specified in the notice at the option of the Holders, which date (the “Change of Control Payment Date”) shall be no earlier than 30 days and no later than 60 days from
the date such notice is delivered. The Change of Control Notice shall, if delivered prior to the date of consummation of the Change of Control, state that the Company’s obligation to repurchase the Notes is conditioned on a Change of Control
Repurchase Event occurring on or prior to the Change of Control Payment Date. 
 (b) On the Change of Control Payment Date, the Company
shall, to the extent lawful: 
 (i) accept for payment all the Notes or portions of the Notes properly tendered pursuant to
the Change of Control Notice; 
 (ii) deposit with the Paying Agent an amount equal to the aggregate repurchase price in
respect of all the Notes or portions of the Notes properly tendered; and 
 (iii) deliver or cause to be delivered to the
Trustee the Notes properly accepted, together with an Officers’ Certificate stating the aggregate principal amount of Notes being repurchased by the Company. 

(c) The Paying Agent shall promptly deliver to each Holder of Notes properly tendered the repurchase price for the Notes, and the Trustee
shall promptly authenticate and mail (or cause to be transferred by book-entry) to each Holder a new Note equal in principal amount to any unpurchased portion of any Notes surrendered. 

(d) Notwithstanding the foregoing in this Section 4.02, the Company shall not be required to make a Change of Control Offer in connection
with a Change of Control Repurchase Event if a third party makes such an offer in connection with such Change of Control Repurchase Event in the manner and at the times required and otherwise in compliance with the requirements for such a Change of
Control Offer made by the Company, and such third party purchases all Notes properly tendered and not withdrawn under its offer. 
 (e) If
Holders of not less than 95% in aggregate principal amount of the outstanding Notes of a Series validly tender and do not withdraw such Notes in a Change of Control Offer and the Company, or any third party making a Change of Control Offer in lieu
of the Company pursuant to Section 4.02(d) above, purchases all of the Notes validly tendered and not withdrawn by such Holders, the Company shall have the right, upon not less than 10 nor more than 60 days’ prior notice, given not more
than 30 days following such purchase pursuant to the Change of Control Offer described in Section 4.02(b) above, to redeem all Notes of such Series that remain outstanding following such purchase at a Redemption Price in cash equal to 101% of
the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding the Redemption Date (subject to the right of Holders of record on a Record Date to receive interest on the relevant Interest Payment Date). 

  
 14 

 (f) The Company shall comply with the requirements of Rule
14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with any repurchase of the Notes as a result of a
Change of Control Repurchase Event. To the extent the provisions of any such securities laws or regulations conflict with this Section 4.02, the Company shall comply with those securities laws and regulations and shall not be deemed to have
breached its obligations under this Section 4.02 by virtue thereof; provided that the Company otherwise uses commercially reasonable efforts to permit Holders to exercise their rights and to fulfill its obligations in the time and in the
manner specified in this Section 4.02 to the extent permitted by such securities laws or regulations. 
 ARTICLE 5 

COVENANTS AND REMEDIES 

Section 5.01. Limitation on Liens. (a) The Company shall not, and shall not permit any
of its Restricted Subsidiaries to, create or incur any Lien upon any Principal Property of the Company or any of its Restricted Subsidiaries (whether now existing or owned or hereafter created or acquired), in order to secure any Indebtedness of the
Company or any of its Restricted Subsidiaries unless prior to or at the same time, the Notes (together with, at the Company’s option, any other Indebtedness or guarantees of the Company or any of its Subsidiaries ranking equally in right of
payment with the Notes or such guarantee) are equally and ratably secured with or, at the Company’s option, prior to, such secured Indebtedness, until such time as such Indebtedness or guarantees are no longer secured by such Lien or such
Principal Property is no longer owned by the Company or any of its Restricted Subsidiaries. 
 (b) The foregoing restriction in
Section 5.01(a) above shall not apply to: 
 (1) Liens on Principal Property existing with respect to any Person at the
time such Person becomes a direct or indirect Subsidiary of the Company, provided that such Lien was not incurred in anticipation of such Person becoming a Subsidiary; 

(2) Liens existing on Principal Property at the time of acquisition thereof or at the time of acquisition by the Company or any
of its Subsidiaries of any Person then owning such Principal Property whether or not such existing Liens were given to secure the payment of the purchase price of the Principal Property to which they attach; 

(3) Liens securing Indebtedness of the Company or any of its Subsidiaries owing to the Company or any of its Subsidiaries; 

(4) Liens existing on the date of issuance of the Initial Notes; 

(5) Liens on Principal Property of a Person existing at the time such Person is merged into or consolidated with the Company or
any of its Subsidiaries, at the time such Person becomes a Subsidiary of the Company, or at the time of a sale, lease or other disposition of all or substantially all of the Principal Properties of a Person to the Company or any of its Subsidiaries,
provided that such Lien was not incurred in anticipation of the merger, consolidation, or sale, lease, other disposition or other such transaction; 

  
 15 

 (6) Liens created in connection with a project financed with, and created to
secure, a Non-recourse Obligation; 
 (7) Liens created to secure the Notes; 

(8) Liens imposed by law or arising by operation of law, such as materialmens’, workmen or repairmen, carriers’,
warehousemen’s and mechanic’s Liens and other similar Liens, in each case for sums not yet overdue by more than 60 calendar days or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards
against such Person with respect to which such Person shall then be proceeding with an appeal or other proceedings for review and Liens arising solely by virtue of any statutory or common law provision relating to banker’s Liens, rights of set-off or similar rights and remedies as to deposit accounts or other funds maintained with a creditor depository institution; 

(9) Liens for taxes, assessments or other governmental charges or levies on Principal Property not yet due or payable or
subject to penalties for non-payment or which are being contested in good faith by appropriate proceedings; 

(10) Liens to secure the performance of obligations with respect to statutory or regulatory requirements, bids, trade
contracts, leases, statutory obligations, surety and appeal bonds, performance or return of money bonds and other obligations of a like nature; 

(11) pledges or deposits under workmen’s compensation, unemployment insurance and other social security laws or similar
legislation and Liens of judgment thereunder which are not currently dischargeable, or deposits to secure public or statutory obligations, or deposits in connection with obtaining or maintaining self-insurance or to obtain the benefits of any law,
regulation or arrangement pertaining to workmen’s compensation, unemployment insurance, old age pensions, social security or similar matters, or deposits of cash or obligations of the United States of America to secure surety, appeal or customs
bonds, or deposits in litigation or other proceedings such as, but not limited to, interpleader proceedings; 
 (12) Liens
consisting of easements, rights-of-way, zoning restrictions, restrictions on the use of real property, and defects and irregularities in the title thereto,
landlords’ Liens and other similar Liens none of which interfere materially with the use of the Principal Property covered thereby in the ordinary course of business and which do not, in the Company’s opinion, materially detract from the
value of such Properties; 
 (13) Liens in favor of the United States of America or any state, territory or possession
thereof (or the District of Columbia), or any department, agency, instrumentality or political subdivision of the United States of America or any state, territory or possession thereof (or the District of Columbia), to secure partial, progress,
advance or other payments pursuant to any contract or statute or to secure any Indebtedness incurred for the purpose of financing all or any part of the purchase price or the cost of constructing or improving the Principal Property subject to such
Liens; 

  
 16 

 (14) Liens securing Indebtedness incurred to finance the construction,
acquisition (including acquisition through merger or consolidation), purchase or lease of, or repairs, improvements or additions to, Principal Property (including shares of Capital Stock), plant or equipment of the Company or its Restricted
Subsidiaries; provided, however, that the Lien shall not extend to any other Principal Property owned by the Company or any of its Restricted Subsidiaries at the time the Lien is incurred (other than Principal Property affixed or
appurtenant thereto), and the Indebtedness (other than any interest thereon) secured by the Lien shall not be incurred more than 18 months after the later of the acquisition, completion of construction, repair, improvement, addition or commencement
of full operation of the Principal Property subject to the Lien; 
 (15) Liens incurred to secure cash or investment
management or custodial services in the ordinary course of business or on insurance policies and the proceeds thereof securing the financing of the premiums with respect thereto; 

(16) Liens on the Capital Stock of a Subsidiary that is not a Restricted Subsidiary; 

(17) Liens securing Hedging Obligations designed to protect the Company from fluctuations in interest rates, currencies,
equities or the price of commodities and not for speculative purposes; 
 (18) Liens securing reimbursement obligations with
respect to commercial letters of credit in the ordinary course of business that encumber cash, documents and other Principal Property relating to such letters of credit and proceeds thereof; 

(19) leases or subleases granted to other persons and not interfering in any material respect with the business of the Company
or the business of any of its Subsidiaries and which do not secure any indebtedness; 
 (20) Liens arising from precautionary
Uniform Commercial Code filings or similar filings relating to operating leases entered into in the ordinary course of business; 

(21) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in
connection within the importation of goods in the ordinary course of business; 
 (22) licenses of intellectual property
entered into in the ordinary course of business (including, intercompany licensing of intellectual property between ourselves and any of our subsidiaries and between our subsidiaries in connection with cost-sharing arrangements, distribution,
marketing, make-sell or other similar arrangements) and which do not secure any indebtedness; 
 (23) any interest or title
of a lessor or sublessor under any lease by the Company or any of its Subsidiaries of real property or personal property; 

  
 17 

 (24) Liens on Principal Property incurred in connection with any transaction
permitted under Section 5.02 below; or 
 (25) any extensions, renewals or replacements of any Lien referred to in
clauses (1) through (24) above without increase of the principal of the Indebtedness secured by such Lien (except to the extent of any fees or other costs associated with any such extension, renewal or replacement); provided,
however, that any Liens permitted by any of clauses (1) through (24) above shall not extend to or cover any Principal Property of the Company or any of its Subsidiaries, as the case may be, other than the Principal Property specified in
such clauses and improvements to such Principal Property. 
 (c) Notwithstanding the restrictions set forth in Section 5.01(a) above,
the Company and its Restricted Subsidiaries shall be permitted to incur Indebtedness secured by Liens which would otherwise be subject to the restrictions set forth in Section 5.01(a) above without equally and ratably securing the Notes;
provided that, after giving effect to such Indebtedness and the retirement of any Indebtedness secured by Liens (other than Liens described in clauses (1) through (25) of Section 5.01(b) above) that is being retired substantially
concurrently with such incurrence, the aggregate amount of all Indebtedness secured by Liens (not including Liens permitted under clauses (1) through (25) of Section 5.01(b) above), together with all Attributable Debt outstanding pursuant
to Section 5.02(b) below, does not exceed 7.5% of the Company’s Consolidated Total Assets. The Company and its Restricted Subsidiaries also may, without equally and ratably securing the Notes, create or incur Liens that extend, renew,
substitute or replace (including successive extensions, renewals, substitutions or replacements), in whole or in part, any Lien permitted pursuant to the preceding sentence. 

Section 5.02. Limitation on Sale and Leaseback Transactions. (a) The Company shall not,
and shall not permit any of its Restricted Subsidiaries to, enter into any sale and leaseback transaction for the sale and leasing back of any Principal Property, whether now owned or hereafter acquired, unless: 

(1) such transaction was entered into prior to the date of issuance of the Initial Notes; 

(2) such transaction was for the sale and leasing back to the Company or any of its wholly owned Subsidiaries of any Principal
Property by the Company or a Restricted Subsidiary; 
 (3) such transaction involves a lease for not more than three years
(or which may be terminated by the Company or its Subsidiaries within a period of not more than three years); 
 (4) the
Company would be entitled to incur Indebtedness secured by a Lien with respect to such sale and leaseback transaction without equally and ratably securing the Notes pursuant to Section 5.01(b) above; or 

  
 18 

 (5) the Company or any Restricted Subsidiary applies an amount equal to the
net proceeds from the sale of such Principal Property to the purchase of other Principal Property or assets used or useful in the Company’s or such Restricted Subsidiary’s business or to the retirement of Indebtedness that is pari
passu with the Notes (including the Notes) within 365 days before or after the effective date of any such sale and leaseback transaction, provided that, in lieu of applying such amount to the retirement of pari passu Indebtedness,
the Company may deliver Notes to the Trustee for cancellation, such Notes to be credited at the cost thereof to the Company. 
 (b)
Notwithstanding the restrictions set forth in Section 5.02(a) above, the Company and its Restricted Subsidiaries may enter into any sale and leaseback transaction which would otherwise be subject to the restrictions set forth in
Section 5.02(a) above, if after giving effect thereto the aggregate amount of all Attributable Debt with respect to such transactions (not including Attributable Debt permitted under clauses (1) through (5) of Section 5.02(a) above),
together with all Indebtedness outstanding pursuant to Section 5.01(c) above, does not exceed 7.5% of the Company’s Consolidated Total Assets. 

Section 5.03. Events of Default. (a) Section 5.1 of the Base Indenture shall not apply to
the Notes. Instead, each of the following events shall be an “Event of Default” with respect to a Series of Notes: 

(1) default for 30 days in payment of any interest installment due and payable on any Note of such Series; 

(2) a failure to pay principal of or premium, if any, on any Note of such Series when due at its Stated Maturity, upon optional
redemption or otherwise; 
 (3) a failure by the Company to repurchase Notes of such Series tendered for repurchase following
the occurrence of a Change of Control Repurchase Event in conformity with Section 4.02 of this Second Supplemental Indenture; 

(4) default in the Company’s performance of any other covenant or agreement in respect of the Notes of such Series for 90
days after written notice has been given either to the Company by the Trustee, or to the Company and the Trustee by the Holders of at least 25% in principal amount of the Notes of such Series then outstanding; 

(5) the Company pursuant to or within the meaning of any Bankruptcy Law (i) commences a voluntary case, (ii) consents
to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially all of its Property, (iv) makes a general assignment for the benefit of its creditors
or (v) admits in writing its inability to generally pay its debts as such debts become due; or takes any comparable action under any foreign laws relating to insolvency; and 

(6) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (i) is for relief against
the Company in an involuntary case, (ii) appoints a Custodian of the Company or for all or substantially all of its Property or (iii) orders the winding up or liquidation of the Company; or any similar relief is granted under any foreign
laws; and the order or decree remains unstayed and in effect for 60 days. 

  
 19 

 (b) Any notice of Default given by the Trustee or Holders under this Section must specify
the Default, demand that it be remedied and state that the notice is a “Notice of Default.” 
 (c) Subject to the provisions of
Section 6.1 and 6.2 of the Base Indenture, the Trustee shall not be deemed to have notice or be charged with knowledge of any Default or Event of Default unless a Trust Officer of the Trustee has actual knowledge thereof or unless written
notice thereof shall have been given to the Trustee in accordance with Section 10.2 of the Base Indenture by the Company, the Paying Agent, any Holder or an agent of any Holder and such notice references the Notes and the Indenture. 

Section 5.04. Modification and Waiver. Article VIII of the Base Indenture, as amended by this
Section 5.04, shall apply to the Notes. Section 8.1 of the Base Indenture shall not apply to the Notes. In lieu thereof, the Company, when authorized by a Board Resolution, and the Trustee may amend or modify the Indenture or enter into an
indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect) with respect to any Series of Notes without notice to or the consent of any Holder of Notes of such Series in order to:

 (a) cure any ambiguity, omission, defect or inconsistency, provided that the interests of the Holders are not adversely affected; 

(b) conform the text of the Indenture or the Notes to any corresponding provision of the “Description of Notes” or the
“Description of the Debt Securities” sections of the Prospectus, as evidenced by an Officers’ Certificate; 
 (c) provide for
the issuance of Additional Notes of such Series, subject to the limitations set forth in Section 3.04 of this Second Supplemental Indenture; 

(d) provide for the assumption of the Company’s obligations in the case of a merger or consolidation and the Company’s discharge upon
such assumption provided that Article IV of the Base Indenture is complied with; 
 (e) add covenants or make any change that would
provide any additional rights or benefits to the Holders of the Notes of such Series; 
 (f) add guarantees with respect to the Notes of such
Series; 
 (g) provide for uncertificated Notes of such Series in addition to or in place of certificated Notes of such Series; 

(h) secure the Notes of such Series; 

(i) add or appoint a successor or separate trustee; 

  
 20 

 (j) make any change that does not adversely affect the interests of any Holder of Notes of
such Series; or 
 (k) maintain the qualification of the Indenture under the Trust Indenture Act. 

Section 5.05. References In Base Indenture. References to “clause (d) or (e) of
Section 5.1,” “Section 5.1(a) or (b),” “Section 5.1(d) or (e)” and “clause (c) of Section 5.1” in the Base Indenture shall be deemed to refer to “Section 5.03(a)(5) or
Section 5.03(a)(6),” “Section 5.03(a)(1) or Section 5.03(a)(2),” “Section 5.03(a)(5) or Section 5.03(a)(6)” and “Section 5.03(a)(4)” of this Second Supplemental Indenture,
respectively. 
 Section 5.06. Maintenance of Office or Agency. In accordance with
Section 3.2 of the Base Indenture, the Company shall maintain an office or agency where the Notes may be surrendered for registration of transfer or exchange or for presentation for payment, redemptions or repurchase and where notices and
demands to or upon the Company in respect of the Notes and the Indenture may be served (which initially shall be the Corporate Trust Office). The Company shall give prompt written notice to the Trustee of the location, and any change in the
location, of such office or agency not designated or appointed by the Trustee. If at any time the Company shall fail to maintain any such required office or agency or to furnish the Trustee with the address thereof, such presentations, surrenders,
notices and demands may be made or served at the Corporate Trust Office. 
 Section 5.07. Legal
Holidays. Section 10.7 of the Base Indenture shall be amended with respect to the Notes by deleting the initial dependent clause in the first sentence thereof. 

Section 5.08. Defeasance and Discharge. Article VII of the Base Indenture shall apply to the
Notes. 
 Section 5.09 No Additional Amounts. No Additional Amounts shall be payable with
respect to the Notes. Section 3.5 of the Base Indenture shall therefore not apply to the Notes. 

Section 5.10 SEC Reports. Section 3.4 of the Base Indenture shall not apply to the Notes.
Instead, the Company shall, to the extent required by Section 314(a) of the Trust Indenture Act, file with the Trustee, within 15 days after the filing with the SEC, copies of the annual reports and of the information, documents and other
reports (or copies of such portions of any of the foregoing as the SEC may by rules and regulations prescribe) which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act (other than confidential
filings, documents subject to confidential treatment and correspondence with the SEC); provided that the delivery of materials to the Trustee by electronic means or filing of documents via the EDGAR system (or any successor electronic filing
system) shall be deemed to be filed with the Trustee as of the time such documents are filed via EDGAR (or such successor system), it being understood that delivery of such reports, information and documents to the Trustee is for informational
purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein and the Trustee shall have no obligation to determine whether or
not such information, documents or reports have 

  
 21 

 
been filed pursuant to the EDGAR system (or its successor). In the event the Company is at any time no longer subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act, it shall, for so long as the Notes remain outstanding, provide copies to the Trustee of the annual reports and of the information, documents and other reports which the Company would have been required to file with the SEC if the Company had
continued to be subject to such Sections 13 or 15(d). 
 ARTICLE 6 

MISCELLANEOUS 

Section 6.01. Confirmation of Indenture. The Base Indenture, as supplemented and amended by
this Second Supplemental Indenture, is in all respects ratified and confirmed, and the Base Indenture and this Second Supplemental Indenture shall be read, taken and construed as one and the same instrument. 

Section 6.02. Counterparts. This Second Supplemental Indenture may be executed in any number
of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. The exchange of copies of this Second
Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Second Supplemental Indenture as to the parties hereto and may be used in lieu of the original Second
Supplemental Indenture and signature pages for all purposes. 
 Section 6.03. Governing Law;
Waiver of Jury Trial. THIS SECOND SUPPLEMENTAL INDENTURE AND THE NOTES SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN SUCH STATE. EACH OF THE COMPANY, THE TRUSTEE AND EACH HOLDER
HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SECOND SUPPLEMENTAL INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED
HEREBY. 
 To the fullest extent permitted by applicable law, each of the Company and the Trustee hereby irrevocably submits to the
jurisdiction of any federal or State court located in the Borough of Manhattan in The City of New York, New York in any suit, action or proceeding based on or arising out of or relating to this Second Supplemental Indenture or any Notes and
irrevocably agrees that all claims in respect of such suit or proceeding may be determined in any such court. Each of the Company and the Trustee irrevocably waives, to the fullest extent permitted by law, any objection which it may have to the
laying of the venue of any such suit, action or proceeding brought in an inconvenient forum. Each of the Company and the Trustee agrees that final judgment in any such suit, action or proceeding brought in such a court shall be conclusive and
binding upon the Company or the Trustee, as applicable, and may be enforced in any courts to the jurisdiction of which the Company or the Trustee, as applicable, is subject by a suit upon such judgment, provided, that service of process is
effected upon the Company or the Trustee, as applicable, in the manner specified herein or as otherwise permitted by law. 

  
 22 

 Section 6.04. Recitals by the Company.
The recitals in this Second Supplemental Indenture are made by the Company only and not by the Trustee, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of
this Second Supplemental Indenture or of the Notes. The Trustee shall not be accountable for the use or application by the Company of the Notes or the proceeds thereof. All of the provisions contained in the Base Indenture in respect of the rights,
privileges, immunities, powers and duties of the Trustee shall be applicable in respect of the Notes and of this Second Supplemental Indenture as fully and with like effect as if set forth herein in full. 

[Signature pages follow] 

  
 23 

 IN WITNESS WHEREOF, the parties have caused this Second Supplemental Indenture to be duly
executed as of the date first written above. 
  

					
	ELECTRONIC ARTS INC.
		
	By:	 	 /s/ Roch LeBlanc

		 	Name:	 	Roch LeBlanc
		 	Title:	 	Vice President, Treasurer
	
	 U.S. BANK NATIONAL ASSOCIATION,

as Trustee

		
	By:	 	 /s/ Lauren Costales

		 	Name:	 	Lauren Costales
		 	Title:	 	Assistant Vice President

 [Signature Page – Second Supplemental Indenture] 

 EXHIBIT A 

FORM OF 2031 NOTE 
 (FACE
OF 2031 NOTE) 
 THIS SECURITY IS ISSUED IN GLOBAL FORM AND REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”) OR A NOMINEE THEREOF. UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC, TO THE COMPANY (AS DEFINED BELOW) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED
IN THE NAME OF CEDE & CO., OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY
TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM IN ACCORDANCE WITH THE TERMS HEREOF AND OF
THE INDENTURE (AS DEFINED BELOW), THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITORY. 

  
 A-1 

 ELECTRONIC ARTS INC. 

1.850% Senior Notes due 2031 
  

			
	No. ________________	  	CUSIP No.: 285512AE9
		  	ISIN No.: US285512AE93
		  	Initially $________________

 ELECTRONIC ARTS INC., a Delaware corporation, promises to pay to CEDE & CO., or registered assigns,
the principal sum set forth on the Schedule of Exchanges of Securities attached hereto on February 15, 2031. 
 Interest Payment Dates:
February 15 and August 15. 
 Record Dates: February 1 and August 1. 

Additional provisions of this Security are set forth on the reverse hereof. 

  
 A-2 

 IN WITNESS WHEREOF, the Company has caused this Security to be signed manually or by
facsimile by its duly authorized officers. 
  

			
	ELECTRONIC ARTS INC.
		
	By:	 	  

		 	Name:
		 	Title:
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	 TRUSTEE’S CERTIFICATE
 OF
AUTHENTICATION:

	
	 U.S. Bank National Association,
 as
Trustee, certifies that this is
 one of the Securities referred to

in the Indenture.

		
	By:                                     
                                         
       	  	Dated:                                     
 
	 Authorized Signatory
	  	

  
 A-3 

 (REVERSE OF 2031 NOTE) 

ELECTRONIC ARTS INC. 

1.850% Senior Notes due 2031 

(1) Interest. Electronic Arts Inc., a Delaware corporation (such corporation, and its successors and assigns under the Indenture
referred to below, being herein called the “Company”), promises to pay interest on the principal amount of this Note at the interest rate per annum shown above. The Company shall pay interest semiannually in arrears on
February 15 and August 15 of each year, beginning on August 15, 2021. Interest on the Securities of this Series shall accrue from the most recent Interest Payment Date to or for which interest has been paid or duly provided for or, if
no interest has been paid or duly provided for, from February 11, 2021. Interest shall be computed on the basis of a 360-day year consisting of twelve 30-day
months. 
 (2) Method of Payment. The Company shall pay interest on the Securities of this Series (except Defaulted Interest) to the
persons who are registered Holders of Securities of this Series at the close of business on the Record Date next preceding the Interest Payment Date even though such Securities are canceled after the Record Date and on or before the Interest Payment
Date. Holders must surrender Securities to a Paying Agent to collect principal payments. The Company shall pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts.
Payment of principal of and premium, if any, and interest on this Note shall be made in immediately available funds to the Depository or its nominee, as the case may be, as the registered Holder of this Global Security. 

(3) Paying Agent, Transfer Agent and Registrar. Initially, U.S. Bank National Association, a national banking association (the
“Trustee”), shall act as Paying Agent, transfer agent and Registrar. The Company may change any Paying Agent, transfer agent, Registrar or co-registrar without notice. The Company may act as
Paying Agent, transfer agent, Registrar or co-registrar. 
 (4) Indenture. This Note is a
“Security” and the Notes are a “Series” of “Securities” under the Indenture (as defined below). The Company issued the Securities of this Series under an Indenture dated as of February 24, 2016 (the “Base
Indenture”), as supplemented by the Second Supplemental Indenture dated as of February 11, 2021 (the “Second Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), in each
case between the Company and the Trustee. The Securities are unsecured general obligations of the Company and constitute the Series designated on the face hereof as the “1.850% Senior Notes due 2031,” initially limited to $750,000,000 in
aggregate principal amount. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S. Code Sections 77aaa-77bbbb) (the “TIA”).
Capitalized terms used herein but not defined herein are used as defined in the Indenture. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and the TIA for a statement of such terms. To the extent any
provision of this Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 

  
 A-4 

 (5) Redemption. The Company may redeem the Securities of this Series in whole at any
time or from time to time in part prior to their Stated Maturity, at its option, pursuant to the following terms: 
 (a) At
any time before November 15, 2030, the Redemption Price shall be equal to the greater of (i) 100% of the aggregate principal amount of the Securities of this Series to be redeemed and (ii) the sum of the present value of the Remaining
Scheduled Payments of such Securities, less accrued and unpaid interest thereon to, but excluding, the Redemption Date for such Securities, discounted to the Redemption Date on a semi-annual basis (assuming a
360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate plus 12.5 basis points, plus accrued and unpaid interest thereon
to, but excluding, the Redemption Date. 
 (b) At any time on or after November 15, 2030, the Redemption Price shall be
equal to 100% of the aggregate principal amount of the Securities of this Series to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date. 

Notwithstanding the foregoing, installments of interest on Securities that are due and payable on Interest Payment Dates falling on or prior
to a Redemption Date shall be payable on the Interest Payment Date to the registered Holders as of the close of business on the relevant Record Date in accordance with the provisions of the Securities and the Indenture. 

On and after the Redemption Date for the Securities, interest shall cease to accrue on such Securities or any portion thereof called for
redemption, unless the Company defaults in the payment of the Redemption Price and accrued interest, if any. On or before the Redemption Date for the Securities, the Company shall deposit with the Trustee or a Paying Agent, funds sufficient to pay
the Redemption Price of the Securities to be redeemed on the Redemption Date, and (except if the Redemption Date shall be an Interest Payment Date) accrued interest, if any. If less than all of the Securities of a Series are to be redeemed, the
Securities to be redeemed shall be selected in accordance with the procedures of the Depository; provided, however, that in no event shall Securities of a principal amount of $2,000 or less be redeemed in part. 

Notice of any redemption shall be delivered at least 10 days but not more than 60 days before the Redemption Date to each Holder of
the Securities to be redeemed. Such notice shall state the Redemption Price (if known) or the formula pursuant to which the Redemption Price is to be determined if the Redemption Price cannot be determined at the time the notice is given. If the
Redemption Price cannot be determined at the time such notice is to be given, the actual Redemption Price, calculated as set forth in the Indenture, shall be set forth in an Officers’ Certificate of the Company delivered to the Trustee no later
than two Business Days prior to the Redemption Date. Notice of redemption having been given as provided in the Indenture, the Securities called for redemption shall become due and payable on the Redemption Date and at the applicable Redemption
Price, plus accrued and unpaid interest, if any, to, but excluding, the Redemption Date. 

  
 A-5 

 (6) Change of Control Repurchase Event. If a Change of Control Repurchase Event
occurs with respect to the Securities of this Series, unless the Company shall have exercised its option pursuant to Section (5) hereof to redeem the Securities of this Series, each Holder of the Securities of this Series shall have the right
to require the Company to repurchase all or any part (equal to $2,000 and multiples of $1,000 in excess thereof) of that Holder’s Securities of such Series at a repurchase price in cash equal to 101% of the aggregate principal amount of the
Securities to be repurchased plus any accrued and unpaid interest on such Securities to, but excluding, the repurchase date. 
 Within
30 days following any Change of Control Repurchase Event with respect to the Securities of this Series or, at the option of the Company, prior to any Change of Control, but after the public announcement of the Change of Control or event that
may constitute the Change of Control, the Company shall deliver a notice (the “Change of Control Notice”) to each Holder of the Securities, with a copy to the Trustee, describing the transaction or transactions that constitute or
may constitute the Change of Control Repurchase Event and offering (the “Change of Control Offer”) to repurchase such Securities on the repurchase date specified in the notice at the option of the Holders, which date (the
“Change of Control Payment Date”) shall be no earlier than 30 days and no later than 60 days from the date such notice is delivered. The Change of Control Notice shall, if delivered prior to the date of consummation of the
Change of Control, state that the Company’s obligation to repurchase the Securities is conditioned on a Change of Control Repurchase Event occurring on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company shall, to the extent lawful: 

(i) accept for payment all the Securities or portions of the Securities properly tendered pursuant to the Change of Control
Notice; 
 (ii) deposit with the Paying Agent an amount equal to the aggregate repurchase price in respect of all the
Securities or portions of the Securities properly tendered; and 
 (iii) deliver or cause to be delivered to the Trustee the
Securities properly accepted, together with an Officers’ Certificate stating the aggregate principal amount of the Securities being repurchased by the Company. 

If Holders of not less than 95% in aggregate principal amount of the outstanding Securities of this Series validly tender and do not withdraw
such Securities in a Change of Control Offer and the Company, or any third party making a Change of Control Offer in lieu of the Company pursuant to Section 4.02(d) of the Second Supplemental Indenture, purchases all of the Securities validly
tendered and not withdrawn by such Holders, the Company shall have the right, upon not less than 10 nor more than 60 days’ prior notice, given not more than 30 days following such purchase pursuant to the Change of Control Offer described
above, to redeem all Securities of this Series that remain outstanding following such purchase at a Redemption Price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding the Redemption
Date (subject to the right of Holders of record on a Record Date to receive interest on the relevant Interest Payment Date). 

  
 A-6 

 The Company shall comply with the requirements of Rule
14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with any repurchase of the Securities as a result of
a Change of Control Repurchase Event. To the extent the provisions of any such securities laws or regulations conflict with this Section (6), the Company shall comply with those securities laws and regulations and shall not be deemed to have
breached its obligations under this Section (6) by virtue thereof; provided that the Company otherwise uses commercially reasonable efforts to permit Holders to exercise their rights and to fulfill its obligations in the time and in the
manner specified in this Section (6) to the extent permitted by such securities laws or regulations. 
 (7) Denominations; Transfer;
Exchange. The Securities of this Series are in registered form without coupons in minimum denominations of $2,000 and any multiple of $1,000 in excess thereof. The transfer of Securities may be registered and Securities may be exchanged as
provided in the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. The Company shall not be
required (A) to transfer or exchange any Securities subject to redemption during a period beginning at the opening of business 15 days before the day of the electronic delivery or mailing of a notice of redemption and ending at the close of
business on the day of such electronic delivery or mailing or (B) to register the transfer of or exchange any Security so selected for redemption, in whole or in part, except the unredeemed portion of any Security being redeemed in part. 

(8) Defeasance. Subject to certain conditions as provided in the Indenture, the Company at any time may terminate some or all of its
obligations under the Securities of this Series and the Indenture if the Company deposits with the Trustee money and/or U.S. Government Obligations for the payment of principal and interest on the Securities of this Series to their Stated Maturity.

 (9) Persons Deemed Owners. The registered Holder of a Security may be treated as its owner for all purposes, except that interest
(other than Defaulted Interest) shall be paid to the Person that was the registered Holder on the relevant Record Date for such payment of interest. 

(10) Amendments and Waivers. Subject to certain exceptions, (i) the Indenture or the Securities of this Series may be amended or
supplemented with respect to this Series with the consent of the Holders of a majority in principal amount of the Securities of this Series; and (ii) any existing default with respect to the Securities of this Series may be waived with the
consent of the Holders of a majority in principal amount of the Securities of this Series. Without the consent of any Securityholder of this Series, the Indenture or the Securities of this Series may be amended or supplemented in accordance with
Section 5.04 of the Second Supplemental Indenture to, among other things, cure any ambiguity, omission, defect or inconsistency, to provide for assumption of Company obligations to Securityholders of this Series or to provide for uncertificated
Securities of this Series in addition to or in place of certificated Securities of this Series , to provide for guarantees with respect to, or security for, the Securities of this Series, or to comply with the TIA or to add additional covenants or
additional rights or benefits to the Securityholders of this Series, or to make any change that does not adversely affect the rights of any Securityholder of this Series. 

  
 A-7 

 (11) Remedies. If an Event of Default with respect to the Securities of this
Series occurs and is continuing, the Trustee or Holders of at least 25% in aggregate principal amount of the Securities of this Series may, by notice in writing to the Company and the Trustee if given by the Holders, declare all the Securities of
this Series to be due and payable immediately. Securityholders may not enforce the Indenture or the Securities of this Series except as provided in the Indenture. The Trustee may require an indemnity before it enforces the Indenture or the
Securities. Subject to certain limitations, Holders of a majority in principal amount of the outstanding Securities of this Series may direct the Trustee in its exercise of any trust or power with respect to the Securities of this Series. The
Trustee may withhold from Securityholders of this Series notice of any Default or Event of Default (except a Default in payment of principal or interest) if it determines in good faith that withholding notice is in their interests. The Company must
furnish an annual compliance certificate to the Trustee. 
 (12) Trustee Dealings with Company. Subject to the provisions of the
TIA, the Trustee under the Indenture, in its individual or any other capacity, may make loans to, accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were
not Trustee. The Trustee shall initially be U.S. Bank National Association. 
 (13) No Recourse Against Others. A director,
officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their
creation. Each Securityholder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities. 

(14) Authentication. This Security shall not be valid until authenticated by the manual signature of an authorized signatory of
the Trustee or an authenticating agent. 
 (15) Abbreviations. Customary abbreviations may be used in the name of a
Securityholder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to
Minors Act). 
 (16) Governing Law. THIS NOTE SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE
AND TO BE PERFORMED IN SUCH STATE. 
 Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification
Procedures the Company has caused CUSIP numbers to be printed on the Securities. No representation is made as to the accuracy of such numbers (or as to the accuracy of ISIN numbers or similar numbers) as printed on the Securities and reliance may be
placed only on the other identification numbers placed thereon. 

  
 A-8 

 THE COMPANY WILL FURNISH TO ANY SECURITYHOLDER UPON WRITTEN REQUEST AND WITHOUT CHARGE A
COPY OF THE INDENTURE, WHICH HAS IN IT THE TEXT OF THIS SECURITY, IN TWELVE-POINT TYPE. REQUESTS MAY BE MADE TO: INVESTOR RELATIONS DIRECTOR, ELECTRONIC ARTS INC., 209 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA 94065, Telephone: (650) 628-0255. 

  
 A-9 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 

I or we assign and transfer this Security to 

(Insert assignee’s soc. sec. or tax I.D. No.) 

(Print or type assignee’s name, address and zip code) 

and irrevocably appoint ________________ agent to transfer this Security on the books of the Company. The agent may substitute another to act for him. 

 
  

Dated: ________________________________ Signed: _______________________________________________ 

(Sign exactly as your name appears
on                                         
                                         
           
 the other side of this
Security)                                        
                                         
                          

Signature Guarantee: ________________________________ 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements
include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for,
STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 
  

 

  
 A-10 

 SCHEDULE OF EXCHANGES OF SECURITIES 

The initial principal amount of this Global Security is ________________ DOLLARS ($________________). The following exchanges of a part of this Global
Security for certificated Securities or a part of another Global Security have been made: 
  

									
	 Date of Exchange
	 	 Amount of decrease

in principal amount
 of this
Global Security
	 	 Amount of increase

in principal amount
 of this
Global Security
	  	 Principal amount of

this Global Security

following such
 decrease
(or
 increase)
	  	 Signature of

authorized signatory of

Trustee

  
 A-11 

 REPURCHASE EXERCISE NOTICE UPON A CHANGE OF CONTROL REPURCHASE EVENT 

To: Electronic Arts Inc. 
 The undersigned
registered owner of this Security hereby acknowledges receipt of a notice from Electronic Arts Inc. (the “Company”) as to the occurrence of a Change of Control Repurchase Event with respect to the Company and hereby directs the
Company to pay, or cause the Trustee to pay,                  an amount in cash equal to 101% of the aggregate principal amount of the
Securities, or the portion thereof (which is $2,000 principal amount or a multiple of $1,000 in excess thereof) below designated, to be repurchased plus interest accrued and unpaid to, but excluding, the repurchase date, except as provided in the
Indenture. The undersigned hereby agrees that the Securities will be repurchased as of the Change of Control Payment Date pursuant to the terms and conditions thereof and the Indenture. 

Dated: ________________________________ 

Signature: _____________________________ 

Principal amount to be repurchased (at least $2,000 or a multiple of $1,000 in excess thereof):
                 
 Remaining
principal amount following such repurchase:                  

By: ________________________________ 

        Authorized Signatory 

  
 A-12 

 EXHIBIT B 

FORM OF 2051 NOTE 
 (FACE
OF 2051 Note) 
 THIS SECURITY IS ISSUED IN GLOBAL FORM AND REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”) OR A NOMINEE THEREOF. UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC, TO THE COMPANY (AS DEFINED BELOW) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED
IN THE NAME OF CEDE & CO., OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY
TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM IN ACCORDANCE WITH THE TERMS HEREOF AND OF
THE INDENTURE (AS DEFINED BELOW), THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITORY. 

  
 B-1 

 ELECTRONIC ARTS INC. 

2.950% Senior Notes due 2051 
  

			
	No. ________________	  	CUSIP No.: 285512AF6
		  	ISIN No.: US285512AF68
		  	Initially $________________

 ELECTRONIC ARTS INC., a Delaware corporation, promises to pay to CEDE & CO., or registered assigns,
the principal sum set forth on the Schedule of Exchanges of Securities attached hereto on February 15, 2051. 
 Interest Payment Dates:
February 15 and August 15. 
 Record Dates: February 1 and August 1. 

Additional provisions of this Security are set forth on the reverse hereof. 

  
 B-2 

 IN WITNESS WHEREOF, the Company has caused this Security to be signed manually or by
facsimile by its duly authorized officers. 
  

			
	ELECTRONIC ARTS INC.
		
	By:	 	  

		 	Name:
		 	Title:
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	 TRUSTEE’S CERTIFICATE
 OF
AUTHENTICATION:

	
	 U.S. Bank National Association,
 as
Trustee, certifies that this is
 one of the Securities referred to

in the Indenture.

		
	By:                                     
                                     	  	Dated:                                     
             
	 Authorized Signatory
	  	

  
 B-3 

 (REVERSE OF 2051 NOTE) 

ELECTRONIC ARTS INC. 

2.950% Senior Notes due 2051 

(1) Interest. Electronic Arts Inc., a Delaware corporation (such corporation, and its successors and assigns under the Indenture
referred to below, being herein called the “Company”), promises to pay interest on the principal amount of this Note at the interest rate per annum shown above. The Company shall pay interest semiannually in arrears on
February 15 and August 15 of each year, beginning on August 15, 2021. Interest on the Securities of this Series shall accrue from the most recent Interest Payment Date to or for which interest has been paid or duly provided for or, if
no interest has been paid or duly provided for, from February 11, 2021. Interest shall be computed on the basis of a 360-day year consisting of twelve 30-day
months. 
 (2) Method of Payment. The Company shall pay interest on the Securities of this Series (except Defaulted Interest) to the
persons who are registered Holders of Securities of this Series at the close of business on the Record Date next preceding the Interest Payment Date even though such Securities are canceled after the Record Date and on or before the Interest Payment
Date. Holders must surrender Securities to a Paying Agent to collect principal payments. The Company shall pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts.
Payment of principal of and premium, if any, and interest on this Note shall be made in immediately available funds to the Depository or its nominee, as the case may be, as the registered Holder of this Global Security. 

(3) Paying Agent, Transfer Agent and Registrar. Initially, U.S. Bank National Association, a national banking association (the
“Trustee”), shall act as Paying Agent, transfer agent and Registrar. The Company may change any Paying Agent, transfer agent, Registrar or co-registrar without notice. The Company may act as
Paying Agent, transfer agent, Registrar or co-registrar. 
 (4) Indenture. This Note is a
“Security” and the Notes are a “Series” of “Securities” under the Indenture (as defined below). The Company issued the Securities of this Series under an Indenture dated as of February 24, 2016 (the “Base
Indenture”), as supplemented by the Second Supplemental Indenture dated as of February 11, 2021 (the “Second Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), in each
case between the Company and the Trustee. The Securities are unsecured general obligations of the Company and constitute the Series designated on the face hereof as the “2.950% Senior Notes due 2051,” initially limited to $750,000,000 in
aggregate principal amount. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S. Code Sections 77aaa-77bbbb) (the “TIA”).
Capitalized terms used herein but not defined herein are used as defined in the Indenture. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and the TIA for a statement of such terms. To the extent any
provision of this Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 

  
 B-4 

 (5) Redemption. The Company may redeem the Securities of this Series in whole at any
time or from time to time in part prior to their Stated Maturity, at its option, pursuant to the following terms: 
 (a) At
any time before August 15, 2050, the Redemption Price shall be equal to the greater of (i) 100% of the aggregate principal amount of the Securities of this Series to be redeemed and (ii) the sum of the present value of the Remaining
Scheduled Payments of such Securities, less accrued and unpaid interest thereon to, but excluding, the Redemption Date for such Securities, discounted to the Redemption Date on a semi-annual basis (assuming a
360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate plus 15.0 basis points, plus accrued and unpaid interest thereon
to, but excluding, the Redemption Date. 
 (b) At any time on or after August 15, 2050, the Redemption Price shall be
equal to 100% of the aggregate principal amount of the Securities of this Series to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date. 

Notwithstanding the foregoing, installments of interest on Securities that are due and payable on Interest Payment Dates falling on or prior
to a Redemption Date shall be payable on the Interest Payment Date to the registered Holders as of the close of business on the relevant Record Date in accordance with the provisions of the Securities and the Indenture. 

On and after the Redemption Date for the Securities, interest shall cease to accrue on such Securities or any portion thereof called for
redemption, unless the Company defaults in the payment of the Redemption Price and accrued interest, if any. On or before the Redemption Date for the Securities, the Company shall deposit with the Trustee or a Paying Agent, funds sufficient to pay
the Redemption Price of the Securities to be redeemed on the Redemption Date, and (except if the Redemption Date shall be an Interest Payment Date) accrued interest, if any. If less than all of the Securities of a Series are to be redeemed, the
Securities to be redeemed shall be selected in accordance with the procedures of the Depository; provided, however, that in no event shall Securities of a principal amount of $2,000 or less be redeemed in part. 

Notice of any redemption shall be delivered at least 10 days but not more than 60 days before the Redemption Date to each Holder of
the Securities to be redeemed. Such notice shall state the Redemption Price (if known) or the formula pursuant to which the Redemption Price is to be determined if the Redemption Price cannot be determined at the time the notice is given. If the
Redemption Price cannot be determined at the time such notice is to be given, the actual Redemption Price, calculated as set forth in the Indenture, shall be set forth in an Officers’ Certificate of the Company delivered to the Trustee no later
than two Business Days prior to the Redemption Date. Notice of redemption having been given as provided in the Indenture, the Securities called for redemption shall become due and payable on the Redemption Date and at the applicable Redemption
Price, plus accrued and unpaid interest, if any, to, but excluding, the Redemption Date. 

  
 B-5 

 (6) Change of Control Repurchase Event. If a Change of Control Repurchase Event
occurs with respect to the Securities of this Series, unless the Company shall have exercised its option pursuant to Section (5) hereof to redeem the Securities of this Series, each Holder of the Securities of this Series shall have the right
to require the Company to repurchase all or any part (equal to $2,000 and multiples of $1,000 in excess thereof) of that Holder’s Securities of such Series at a repurchase price in cash equal to 101% of the aggregate principal amount of the
Securities to be repurchased plus any accrued and unpaid interest on such Securities to, but excluding, the repurchase date. 
 Within
30 days following any Change of Control Repurchase Event with respect to the Securities of this Series or, at the option of the Company, prior to any Change of Control, but after the public announcement of the Change of Control or event that
may constitute the Change of Control, the Company shall deliver a notice (the “Change of Control Notice”) to each Holder of the Securities, with a copy to the Trustee, describing the transaction or transactions that constitute or
may constitute the Change of Control Repurchase Event and offering (the “Change of Control Offer”) to repurchase such Securities on the repurchase date specified in the notice at the option of the Holders, which date (the
“Change of Control Payment Date”) shall be no earlier than 30 days and no later than 60 days from the date such notice is delivered. The Change of Control Notice shall, if delivered prior to the date of consummation of the
Change of Control, state that the Company’s obligation to repurchase the Securities is conditioned on a Change of Control Repurchase Event occurring on or prior to the Change of Control Payment Date. 

On the Change of Control Payment Date, the Company shall, to the extent lawful: 

(i) accept for payment all the Securities or portions of the Securities properly tendered pursuant to the Change of Control
Notice; 
 (ii) deposit with the Paying Agent an amount equal to the aggregate repurchase price in respect of all the
Securities or portions of the Securities properly tendered; and 
 (iii) deliver or cause to be delivered to the Trustee the
Securities properly accepted together with an Officers’ Certificate stating the aggregate principal amount of the Securities being repurchased by the Company. 

If Holders of not less than 95% in aggregate principal amount of the outstanding Securities of this Series validly tender and do not withdraw
such Securities in a Change of Control Offer and the Company, or any third party making a Change of Control Offer in lieu of the Company pursuant to Section 4.02(d) of the Second Supplemental Indenture, purchases all of the Securities validly
tendered and not withdrawn by such Holders, the Company shall have the right, upon not less than 10 nor more than 60 days’ prior notice, given not more than 30 days following such purchase pursuant to the Change of Control Offer described
above, to redeem all Securities of this Series that remain outstanding following such purchase at a Redemption Price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding the Redemption
Date (subject to the right of Holders of record on a Record Date to receive interest on the relevant Interest Payment Date). 

  
 B-6 

 The Company shall comply with the requirements of Rule
14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with any repurchase of the Securities as a result of
a Change of Control Repurchase Event. To the extent the provisions of any such securities laws or regulations conflict with this Section (6), the Company shall comply with those securities laws and regulations and shall not be deemed to have
breached its obligations under this Section (6) by virtue thereof; provided that the Company otherwise uses commercially reasonable efforts to permit Holders to exercise their rights and to fulfill its obligations in the time and in the
manner specified in this Section (6) to the extent permitted by such securities laws or regulations. 
 (7) Denominations; Transfer;
Exchange. The Securities of this Series are in registered form without coupons in minimum denominations of $2,000 and any multiple of $1,000 in excess thereof. The transfer of Securities may be registered and Securities may be exchanged as
provided in the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. The Company shall not be
required (A) to transfer or exchange any Securities subject to redemption during a period beginning at the opening of business 15 days before the day of the electronic delivery or mailing of a notice of redemption and ending at the close of
business on the day of such electronic delivery or mailing or (B) to register the transfer of or exchange any Security so selected for redemption, in whole or in part, except the unredeemed portion of any Security being redeemed in part. 

(8) Defeasance. Subject to certain conditions as provided in the Indenture, the Company at any time may terminate some or all of its
obligations under the Securities of this Series and the Indenture if the Company deposits with the Trustee money and/or U.S. Government Obligations for the payment of principal and interest on the Securities of this Series to their Stated Maturity.

 (9) Persons Deemed Owners. The registered Holder of a Security may be treated as its owner for all purposes, except that interest
(other than Defaulted Interest) shall be paid to the Person that was the registered Holder on the relevant Record Date for such payment of interest. 

(10) Amendments and Waivers. Subject to certain exceptions, (i) the Indenture or the Securities of this Series may be amended or
supplemented with respect to this Series with the consent of the Holders of a majority in principal amount of the Securities of this Series; and (ii) any existing default with respect to the Securities of this Series may be waived with the
consent of the Holders of a majority in principal amount of the Securities of this Series. Without the consent of any Securityholder of this Series, the Indenture or the Securities of this Series may be amended or supplemented in accordance with
Section 5.04 of the Second Supplemental Indenture to, among other things, cure any ambiguity, omission, defect or inconsistency, to provide for assumption of Company obligations to Securityholders of this Series or to provide for uncertificated
Securities of this Series in addition to or in place of certificated Securities of this Series , to provide for guarantees with respect to, or security for, the Securities of this Series, or to comply with the TIA or to add additional covenants or
additional rights or benefits to the Securityholders of this Series, or to make any change that does not adversely affect the rights of any Securityholder of this Series. 

  
 B-7 

 (11) Remedies. If an Event of Default with respect to the Securities of this
Series occurs and is continuing, the Trustee or Holders of at least 25% in aggregate principal amount of the Securities of this Series may, by notice in writing to the Company and the Trustee if given by the Holders, declare all the Securities of
this Series to be due and payable immediately. Securityholders may not enforce the Indenture or the Securities of this Series except as provided in the Indenture. The Trustee may require an indemnity before it enforces the Indenture or the
Securities. Subject to certain limitations, Holders of a majority in principal amount of the outstanding Securities of this Series may direct the Trustee in its exercise of any trust or power with respect to the Securities of this Series. The
Trustee may withhold from Securityholders of this Series notice of any Default or Event of Default (except a Default in payment of principal or interest) if it determines in good faith that withholding notice is in their interests. The Company must
furnish an annual compliance certificate to the Trustee. 
 (12) Trustee Dealings with Company. Subject to the provisions of the
TIA, the Trustee under the Indenture, in its individual or any other capacity, may make loans to, accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were
not Trustee. The Trustee shall initially be U.S. Bank National Association. 
 (13) No Recourse Against Others. A director,
officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their
creation. Each Securityholder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities. 

(14) Authentication. This Security shall not be valid until authenticated by the manual signature of an authorized signatory of the
Trustee or an authenticating agent. 
 (15) Abbreviations. Customary abbreviations may be used in the name of a Securityholder or
an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

(16) Governing Law. THIS NOTE SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED
IN SUCH STATE. 
 Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures the Company has
caused CUSIP numbers to be printed on the Securities. No representation is made as to the accuracy of such numbers (or as to the accuracy of ISIN numbers or similar numbers) as printed on the Securities and reliance may be placed only on the other
identification numbers placed thereon. 

  
 B-8 

 THE COMPANY WILL FURNISH TO ANY SECURITYHOLDER UPON WRITTEN REQUEST AND WITHOUT CHARGE A
COPY OF THE INDENTURE, WHICH HAS IN IT THE TEXT OF THIS SECURITY, IN TWELVE-POINT TYPE. REQUESTS MAY BE MADE TO: INVESTOR RELATIONS DIRECTOR, ELECTRONIC ARTS INC., 209 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA 94065, Telephone: (650) 628-0255. 

  
 B-9 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 

I or we assign and transfer this Security to 

(Insert assignee’s soc. sec. or tax I.D. No.) 

(Print or type assignee’s name, address and zip code) 

and irrevocably appoint ________________ agent to transfer this Security on the books of the Company. The agent may substitute another to act for him. 

 
  
  

							
	Dated:	 	  
	  	Signed:	  	  

		 		  		  	(Sign exactly as your name appears on the other side of this Security)

 Signature Guarantee: ________________________________ 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements
include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for,
STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 
  

 

  
 B-10 

 SCHEDULE OF EXCHANGES OF SECURITIES 

The initial principal amount of this Global Security is ________________ DOLLARS ($________________). The following exchanges of a part of this Global
Security for certificated Securities or a part of another Global Security have been made: 
  

									
	 Date of Exchange
	 	 Amount of decrease

in principal amount
 of this
Global Security
	 	 Amount of increase

in principal amount
 of this
Global Security
	  	 Principal amount of

this Global Security

following such
 decrease
(or
 increase)
	  	 Signature of

authorized signatory of

Trustee

  
 B-11 

 REPURCHASE EXERCISE NOTICE UPON A CHANGE OF CONTROL REPURCHASE EVENT 

To: Electronic Arts Inc. 
 The undersigned
registered owner of this Security hereby acknowledges receipt of a notice from Electronic Arts Inc. (the “Company”) as to the occurrence of a Change of Control Repurchase Event with respect to the Company and hereby directs the
Company to pay, or cause the Trustee to pay,                  an amount in cash equal to 101% of the aggregate principal amount of the
Securities, or the portion thereof (which is $2,000 principal amount or a multiple of $1,000 in excess thereof) below designated, to be repurchased plus interest accrued and unpaid to, but excluding, the repurchase date, except as provided in the
Indenture. The undersigned hereby agrees that the Securities will be repurchased as of the Change of Control Payment Date pursuant to the terms and conditions thereof and the Indenture. 

 

	
	   Dated: ________________________________

	
	   Signature: _____________________________

 Principal amount to be repurchased (at least $2,000 or a multiple of $1,000 in excess thereof):
                 
 Remaining
principal amount following such repurchase:                  
  

			
	By:	 	  

		 	Authorized Signatory

  
 B-12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]